DE102008050430A1 - Anti-dandruff and anti-relapse shampoo - Google Patents

Abstract

A cosmetic composition is claimed which is suitable for effective control of dandruff on hairy body surfaces and an active ingredient combination of A) 0.5 to 20% by weight of at least one anionic sulphate and / or sulphonate surfactant, B) 0.05 to 5 Wt .-% zinc pyrithione a particle size <2 microns and C) 0.05 to 5 wt .-% of a cationic polygalactomannan or a derivative of the cationic polygalactomannan with a cationic charge density of 0.1 to 1.5 meq / g and a Contains molecular weight of 500,000 to 3,000,000. It has been found that treating the hair with the composition also reduces the relapse of dandruff after discontinuation of the agent.

Description

The The invention relates to a cosmetic composition for controlling of dander based on a special combination of active ingredients, a method of treating dander by using the As well as the use of the prophylactic, diminishing, Removal and alleviation of dandruff on hairy body surfaces and to reduce the relapse of dandruff on hairy body regions after discontinuation of the remedy.

cleaning supplies for skin and hair, as for example as liquid Soaps, shampoos, shower baths, bubble baths, shower and wash gels are commercially available not only have good cleaning power, but should continue to be well tolerated for the skin and hair and even with frequent use not too strong degreasing or dryness.

Usually are skin and hair cleaners based on anionic, nonionic and / or amphoteric surfactants Substances, but most preferably based on anionic Formulated surfactants. Although such compositions have a good Washes on, the cosmetic associated with them However, properties are inadequate, especially due to the Removal of skin and hair lipids and proteins from the skin or the hair surface.

a another important aspect of hair cleansing and care the fight against dandruff, because even the easy Appearance of dandruff on the scalp or other hairy body regions is considered a sign of lack of care. Furthermore is usually accompanied by dandruff itching, which as is distracting. An itch, however, causes scratching reactions resulting in injury to the affected skin That, in turn, can be the basis for infections and pathogens Can form pathogens.

in the Generally, taking anti-dandruff treatment is the fight of the Phytosporum ovale yeast fungus, which in the case of excessive Occurrence is causative for cosmetic dandruff. As an effective antidandruff active, the solid has zinc pyrithione proven, but for example in a Shampoomatrix must be stabilized, since he is there in solid, unresolved Form is present. Without adequate stabilization would the Otherwise, the active ingredient will sink to the bottom and the shampoo will lose its weight Lose anti-dandruff action.

The Requirements for a cosmetic remedy for dandruff are therefore high, because on the one hand, the scalp thoroughly and be freed from dandruff on a sustainable basis, and secondly the agent for hair and scalp well tolerated be.

A Another important requirement is as fast as possible Effect, so that the above chain of disadvantages is not first occurs.

After all should the dandruff be sustainable. sustainability in this context means that even after discontinuation of the antidandruff agent greatly retards and / or reduces the formation of new scabies becomes. Ideally, there should be no new growth after weaning the agent more (anti-relapse effect).

Next these effects on the application surface must also the problem of stabilization of the antidandruff drug (zinc pyrithione) dissolved in the matrix of the antidandruff agent.

In Literature and practice is known to be effective stabilization of zinc pyrithione by acrylate polymers (Carbopol types) or Xanthan gum gelling agent.

Of the Use of gelling agents, however, has disadvantages, since these themselves negative for the foaming of a surfactant-containing cleaning agent can affect. They are therefore less suitable for the stabilization of ZnPy (zinc pyrithione) in a hair shampoo, in which an effective foaming is currently being sought.

task It was therefore an object of the present invention to provide an antidandruff agent which meets all the above requirements and in which the anti-dandruff agent (ZnPy) without the compelling presence of Gelling agents is effectively stabilized.

Out The literature is known a variety of hair cosmetic products, prevent or reduce dandruff. To select are usually means in the form of shampoos, lotions or Hair lotions.

adversely So far, the means of the prior art has been that they were effective against dandruff, but this effect only after more frequent Application occurred.

Of others are not anti-dandruff agents in the prior art known to be the sustainable combat dander (Anti-relapse) or the stabilization of ZnPy in a "gellant-free" formulation affect.

Completely surprising It has now been found that the combination of a zinc pyrithione one defined particle size with a specific cationic polymer in a surfactant base the aforementioned Solves requirements to a high degree.

Especially could be found that with the means not only fast and effectively treat scalp dandruff, but that also several weeks after stopping the remedy a significant smaller amount of dandruff occurs than before use of the dandruff Agent. Furthermore, an effective stabilization of the zinc pyrithione in a "gelling agent-free" preparation can be achieved by ZnPy used a particle size <2 microns has been. The foam effect and the foam quality of the agent were thus not impaired.

After all could be due to the compelling presence of a particular cationic Polymers as a further advantage of the invention a gentle treatment the scalp (or hairy body regions) can be achieved and the treated hair also had improved care properties in terms of combability, shine and smoothness on.

• A) 0,5–20 Gew.-% mindestens eines anionischen Sulfat- und/oder Sulfonattensids,
• B) 0,05 bis 5 Gew.-% Zink-Pyrithion einer Partikelgröße < 2 μm und
• C) 0,05 bis 5 Gew.-% eines kationischen Polygalactomannans oder eines Derivats des kationischen Polygalactomannans mit einer kationischen Ladungsdichte von 0,1 bis 1,5 meq/g und einem Molekulargewicht von 500,000 bis 3,000,000.

enthalten.The invention therefore relates to antidandruff agents which, as active ingredient combination - based on their total weight -

• A) 0.5-20% by weight of at least one anionic sulphate and / or sulphonate surfactant,
• B) 0.05 to 5 wt .-% zinc pyrithione a particle size <2 microns and
• C) 0.05 to 5% by weight of a cationic polygalactomannan or a derivative of the cationic polygalactomannan having a cationic charge density of 0.1 to 1.5 meq / g and a molecular weight of 500,000 to 3,000,000.

contain.

It it was found that the invention Means the aforementioned tasks in a specific pH range solve it very well Therefore, inventive Preferred agents having a pH <6, preferably <5.8 and in particular <5.5.

simultaneously must not be below a certain pH, since the Otherwise they are too aggressive to the skin / scalp. optimally, Consequently, the compositions according to the invention have one pH of at least 2.5, preferably of at least 3 and in particular of at least 3.5 on.

When first compelling component contain the inventive Means for achieving effective and gentle cleaning of the Hair and hairy body surfaces at least an anionic surfactant. This is according to the invention to high-foaming anionic sulfate and / or sulfonate surfactants A) with a linear or branched alkyl chain of one chain length from 6 to 20, preferably from 8 to 18 and especially from 10 to 16 C atoms in the molecule, and a degree of ethoxylation of 0 to 10, preferably from 1 to 8 and especially from 2 to 4.

Especially preferred examples according to the invention suitable anionic surfactants A) are the alkali-ammonium and / or di- and Triethanolamine salts 2- or 3-times ethoxylated, branched or straight-chain lauryl, pareth and / or trideceth sulfates such as laureth (2) sulfate, Laureth (3) sulfate, trideceth (2) sulfate and trideceth (3) sulfate. Specific and particularly suitable anionic surfactants are, for example Sodium lauryl ether sulfate (2 EO), sodium lauryl ether sulfate (3 EO), Ammonium lauryl ether sulfate (2 EO), ammonium lauryl ether sulfate (3 EO), Sodium lauryl sulfate, ammonium lauryl sulfate, sodium trideceth sulfate (2 EO), sodium trideceth sulfate (3 EO), ammonium trideceth sulfate (2 EO) EO) and ammonium trideceth sulfate (3 EO).

The or the specific anionic (s) surfactant (s) will be in the Compositions of the invention - based on their total weight - preferably in quantities of 3 to 20 Wt .-%, preferably from 4 to 15 wt .-% and in particular in quantities from 5 to 13 wt .-% used.

Around in terms of cleanliness, mildness and foam quality of the invention In order to create an optimal balance, it has proved to be particularly preferred when in addition to the (n) compelling anionic Surfactant (s) containing at least one other surfactant, from the Group of amphoteric / zwitterionic and / or nonionic Surfactant is selected. Particularly preferred is a ratio of the anionic surfactant A) to the sum of the other surfactants in the Range from 6: 1 to 1: 2, preferably from 5: 1 to 1: 1.5 and in particular in the range of 4.5: 1 to 1: 1.25.

According to the invention suitable zwitterionic surfactants are those surface-active compounds which carry in the molecule at least one quaternary ammonium group and at least one -COO ^(-) - or -SO ₃ ^(-) group. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammoniumglycinate, for example Kokosalkyldimethylammoniumglycinat, N-acyl-aminopropyl-N, N-dimethylammoniumglycinate, for example cocoacylaminopropyl-dimethylammoniumglycinat, and 2-alkyl-3-carboxymethyl 3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.

Amphoteric surfactants according to the invention are understood as meaning those surface-active compounds which, apart from a C ₈ -C ₂₄ -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO ₃ H group and which are capable of forming internal salts are. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C ₁₂ -C ₁₈ acylsarcosine.

The amphoteric / zwitterionic surfactants are in the inventive Means in amounts of 0.05 to 12.5 wt .-%, preferably from 0.1 to 10 wt .-%, more preferably from 0.5 to 7.5 wt .-% and in particular from 1 to 5 wt .-% used - in each case based on the Total weight of the agent.

• – Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 8 bis 30 C-Atomen, an Fettsäuren mit 8 bis 30 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,
• – mit einem Methyl- oder C₂-C₆-Alkylrest endgruppenverschlossene Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 8 bis 30 C-Atomen, an Fettsäuren mit 8 bis 30 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe, wie beispielsweise die unter den Verkaufsbezeichnungen Dehydol^® LS, Dehydol^® LT (Cognis) erhältlichen Typen,
• – C₁₂-C₃₀-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Glycerin,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl, beispielsweise Rizinusöl-hydriert + 40 EO, wie es beispielsweise unter dem Handelsnamen Cremophor CO 455 von der Firma SHC im Handel erhältlich ist,
• – Polyolfettsäureester, wie beispielsweise das Handelsprodukt Hydagen^® HSP (Cognis) oder Sovermol-Typen (Cognis),
• – alkoxylierte Triglyceride,
• – alkoxylierte Fettsäurealkylester der Formel (V) R¹⁴CO-(OCH₂CHR¹⁵)_wOR¹⁶ (V)in der R¹⁴CO für einen linearen oder verzweigten, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22 Kohlenstoffatomen, R¹⁵ für Wasserstoff oder Methyl, R¹⁶ für lineare oder verzweigte Alkylreste mit 1 bis 4 Kohlenstoffatomen und w für Zahlen von 1 bis 20 steht,
• – Aminoxide,
• – Hydroxymischether, wie sie beispielsweise in der DE-OS 19738866 beschrieben sind,
• – Sorbitanfettsäureester und Anlagerungeprodukte von Ethylenoxid an Sorbitanfettsäureester wie beispielsweise die Polysorbate,
• – Zuckerfettsäureester und Anlagerungsprodukte von Ethylenoxid an Zuckerfettsäureester,
• – Anlagerungsprodukte von Ethylenoxid an Fettsäurealkanolamide und Fettamine,
• – Fettsäure-N-alkylglucamide,
• – Alkylpolygykoside entsprechend der allgemeinen Formel RO-(Z)_x wobei R für Alkyl, Z für Zucker sowie x für die Anzahl der Zuckereinheiten steht. Die erfindungsgemäß verwendbaren Alkylpolyglykoside können lediglich einen bestimmten Alkylrest R enthalten. Üblicherweise werden diese Verbindungen aber ausgehend von natürlichen Fetten und Ölen oder Mineralölen hergestellt. In diesem Fall liegen als Alkylreste R Mischungen entsprechend den Ausgangsverbindungen bzw. entsprechend der jeweiligen Aufarbeitung dieser Verbindungen vor.

According to the invention suitable nonionic surfactants contain as hydrophilic group z. A polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether groups. Such compounds are, for example

• - Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 carbon atoms and to alkylphenols having 8 to 15 carbon atoms in the alkyl group,
• - with a methyl or C ₂ -C ₆ alkyl radical end-capped addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 C atoms and onto alkylphenols having 8 to 15 carbon atoms in the alkyl group, such as those available under the trade names Dehydol ^® LS, LT Dehydol ^® types (Cognis),
• C ₁₂ -C ₃₀ -fatty acid mono- and diesters of addition products of 1 to 30 mol of ethylene oxide with glycerol,
• Addition products of from 5 to 60 mol of ethylene oxide onto castor oil and hydrogenated castor oil, for example castor oil-hydrogenated + 40 EO, as it is commercially available, for example, under the trade name Cremophor CO 455 from SHC,
• - polyol, such as the commercially available product ^® Hydagen HSP (Cognis) or Sovermol types (Cognis),
• - alkoxylated triglycerides,
• - alkoxylated fatty acid alkyl esters of the formula (V) R ¹⁴ CO- (OCH ₂ CHR ¹⁵ ) _w OR ¹⁶ (V) in the R ¹⁴ CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R ^{15 is} hydrogen or methyl, R ^{16 is} linear or branched alkyl radicals having 1 to 4 carbon atoms and w is a number from 1 to 20 stands,
• - amine oxides,
• - Hydroxymischether, as described for example in the DE-OS 19738866 are described
• Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates,
• Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters,
• Adducts of ethylene oxide with fatty acid alkanolamides and fatty amines,
• Fatty acid N-alkylglucamides,
• - Alkylpolygykoside according to the general formula RO- (Z) _x wherein R is alkyl, Z is sugar and x is the number of sugar units. The alkyl polyglycosides which can be used according to the invention can only contain one particular alkyl radical R. Usually, however, these compounds are prepared starting from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the particular work-up of these compounds.

• – im wesentlichen aus C₈- und C₁₀-Alkylgruppen,
• – im wesentlichen aus C₁₂- und C₁₄-Alkylgruppen,
• – im wesentlichen aus C₈- bis C₁₆-Alkylgruppen oder
• – im wesentlichen aus C₁₂- bis C₁₆-Alkylgruppen oder
• – im wesentlichen aus C₁₆ bis C₁₈-Alkylgruppen besteht.

Particularly preferred are those alkyl polyglycosides in which R

• Consisting essentially of C ₈ and C ₁₀ -alkyl groups,
• Essentially of C ₁₂ and C ₁₄ alkyl groups,
• - Essentially from C ₈ - to C ₁₆ alkyl groups or
• - Essentially from C ₁₂ - to C ₁₆ alkyl groups or
• - Consists essentially of C ₁₆ to C ₁₈ alkyl groups.

When Sugar building block Z can be any mono- or oligosaccharides be used. Usually, sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides used. Such sugars are, for example, glucose, fructose, galactose, Arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, Idose, talose and sucrose. Preferred sugar building blocks are glucose, Fructose, galactose, arabinose and sucrose; Glucose is special prefers.

The Alkylpolyglycosides which can be used according to the invention contain on average 1.1 to 5 sugar units. Alkylpolyglykoside with x values of 1.1 to 2.0 are preferred. Very particularly preferred are alkyl glycosides in which x is 1.1 to 1.8.

Also the alkoxylated homologs of said alkyl polyglycosides can used according to the invention. These homologs can average up to 10 ethylene oxide and / or Propylene oxide units per Alkylglykosideinheit included.

When preferred nonionic surfactants are the alkylene oxide addition products saturated linear fatty alcohols and fatty acids with in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid. Preparations with excellent properties will also be obtained when they are fatty acid esters as nonionic surfactants of ethoxylated glycerol.

These Connections are identified by the following parameters. The alkyl radical R contains 6 to 22 carbon atoms and can be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals. Such Examples of alkyl radicals are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-Lauryl, 1-myristyl. When using so-called "oxo-alcohols" as Starting materials predominate compounds with an odd Number of carbon atoms in the alkyl chain.

at it may be the compounds with alkyl groups used as surfactant each are uniform substances. It is, however, in usually preferred in the preparation of these substances by native to go out with vegetable or animal raw materials, so that one Substance mixtures with different, from the respective raw material receives dependent alkyl chain lengths.

at the surfactants, the adducts of ethylene and / or propylene oxide represent fatty alcohols or derivatives of these addition products, can both products with a "normal" homolog distribution as well as those with a narrow homolog distribution become. Under "normal" homolog distribution thereby understood mixtures of homologues, which in the implementation of fatty alcohol and alkylene oxide using alkali metals, Alkali metal hydroxides or alkali metal alcoholates as catalysts receives. Narrow homolog distributions are opposed obtained when, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or -alkoholate be used as catalysts. The usage of products with restricted homolog distribution may be preferred be.

According to the invention preferred nonionic surfactants are the ethoxylated fatty alcohols and the Alkyl polyglycosides which are used in the inventive Means - based on their total weight - in one Amount of from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, more preferably from 0.1 to 5% by weight, and more preferably from 0.5 to 3 wt .-% are included.

According to one another embodiment of the invention can the anti-dandruff agents of the invention further cationic surfactants of the quaternary ammonium type, of the esterquats and the amidoamines.

preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, Dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, z. Cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, Distearyldimethylammonium chloride, lauryldimethylammonium chloride, Lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as those under the INCI names Quaternium-27 and Quaternium-83 known imidazolium compounds. The long alkyl chains of the above surfactants mentioned preferably have 10 to 18 carbon atoms.

Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element. Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. Such products are marketed under the trade names Stepantex® ^{®, ®} and Dehyquart® Armocare® ^®. The products Armocare ^® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ^® F-75, Dehyquart ^® C-4046, Dehyquart ^® L80 and Dehyquart ^® AU-35 are examples of such esterquats.

The alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines. An inventively particularly suitable compound from this group of substances under the name Tegoamid ^® S 18 commercial stearamidopropyl dimethylamine is.

The cationic surfactants are in the inventive Agents preferably in amounts of 0.05 to 10 wt .-%, based on the entire remedy, included. Amounts of 0.1 to 5 wt .-% are particularly preferred.

The second mandatory component of the invention By means of the anti-dandruff agent zinc pyrithione, which is in the Matrix of the agent must be effectively stabilized, so too after prolonged storage of the agent no flocculation or no settling of the anti-dandruff drug occurs. This stabilization is possible if the ZnPy with a cationic polymer C) is combined in the aforementioned surfactant base. Of special The advantage for the stabilization is when ZnPy one certain, defined particle size used becomes. This is how the best stabilization results are achieved when at least 85%, preferably at least 90% and in particular at least 95% of the zinc pyrithione particles have an average particle size <1.8 μm, preferably <1.5 μm, more preferably <1.3 μm and in particular <1.0 μm exhibit.

One According to the invention, suitable zinc pyrithione for example, from the company Connect Chemicals under the trade name "Tomicide ZPT 50 "sold. ZnPy is used in the invention Compositions - based on their total weight - in from 0.01 to 5% by weight, preferably from 0.05 to 4% by weight, more preferably from 0.1 to 3% by weight and especially from 0.2 to 2 wt .-% used.

When According to the invention suitable compulsory component C) serves a cationic polygalactomannan or one of its derivatives with a cationic charge density of 0.1 to 1.5 meq / g and a Molecular weight from 500,000 to 3,000,000. It was found that due to the presence of these special cationic polymers in the antidandruff composition has rheological properties the agent (associated with the stabilization of ZnPy) and the Foam quantity and stability are positively influenced can. Furthermore, the cationic polymer causes a conditioning effect on the hair and these become lighter combable and shiny.

When Cationic galactomannans or their derivatives are particularly suitable Derivatives (C)), which have a cationic charge density of 0.2 to 1.3 meq / g, preferably from 0.3 to 1.1 meq / g and especially from 0.4 to 0.9 meq / g and a molecular weight of 700,000 to 2,000,000, preferably from 900,000 to 1,750,000, more preferably from 1,000,000 up to 1,500,000 and especially from 1,150,000 to 1,400,000.

she are in the compositions of the invention - on their total weight - in an amount of 0.01 to 5% by weight, preferably from 0.02 to 4% by weight, more preferably from 0.05 to 3% by weight and in particular from 0.1 to 2 wt .-% used.

Examples of the present invention suitable commercial products are, for example, under the trade name Jaguar ^® 162 ^® Jaguar C13S and Jaguar ^® Excel from Rhodia, and N-Hance 3196 ^® products sold by Hercules.

Next The anti-dandruff effect is also the conditioning and care Hair and scalp an important aspect of the invention. It is therefore inventively advantageous if the Antidandruff agent in addition to the above-mentioned mandatory components to support the moisture retention capacity of Skin and hair continue to contain an active substance complex, that of D-panthenol and at least one other vitamin, one Vitamin precursor or a vitamin derivative or at least one Protein hydrolyzate exists.

D-panthenol is in the compositions of the invention - on their total weight - in an amount of 0.01 to 3% by weight, preferably from 0.02 to 2% by weight, more preferably from 0.05 to 1% by weight and in particular from 0.1 to 0.5 wt .-% used.

The Ratio of panthenol to vitamin (vitamin precursor or derivative) or protein hydrolyzate is preferred in the range of 50: 1 to 1:20, preferably from 30: 1 to 1:10, more preferably from 25: 1 to 1: 5 and in particular from 20: 1 to 1: 3.

Under According to the invention preferred vitamins, provitamins and vitamin precursors and their derivatives are such representatives usually understood to belong to groups A, B, C, E, F and H are assigned.

The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The β-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The agents according to the invention preferably contain the vitamin A component in amounts of 0.01-1% by weight, based on the total preparation.

• Vitamin B₁ (Thiamin)
• Vitamin B₂ (Riboflavin)
• Vitamin B₃. Unter dieser Bezeichnung werden häufig die Verbindungen Nicotinsäure und Nicotinsäureamid (Niacinamid) geführt.

The vitamin B group or the vitamin B complex include, among others

• Vitamin B ₁ (thiamine)
• Vitamin B ₂ (riboflavin)
• Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.

• Vitamin B₆ (Pyridoxin sowie Pyridoxamin und Pyridoxal).

Preferred according to the invention is the nicotinic acid amide, which is preferably present in the agents according to the invention in amounts of from 0.05 to 1% by weight, based on the total agent.

• Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).

• Vitamin C (Ascorbinsäure). Vitamin C wird in den erfindungsgemäß verwendeten Mitteln bevorzugt in Mengen von 0,01 bis 3 Gew.-%, bezogen auf das gesamte Mittel eingesetzt. Die Verwendung in Form des Palmitinsäureesters, der Glucoside oder Phosphate kann bevorzugt sein. Die Verwendung in Kombination mit Tocopherolen kann ebenfalls bevorzugt sein.
• Vitamin E (Tocopherole, insbesondere α-Tocopherol). Tocopherol und seine Derivate, worunter insbesondere die Ester wie das Acetat, das Nicotinat, das Phosphat und das Succinat fallen, sind in den erfindungsgemäß verwendeten Mitteln bevorzugt in Mengen von 0,01–1 Gew.-%, bezogen auf das gesamte Mittel, enthalten.
• Vitamin F. Unter dem Begriff „Vitamin F” werden üblicherweise essentielle Fettsäuren, insbesondere Linolsäure, Linolensäure und Arachidonsäure, verstanden.
• Vitamin H. Als Vitamin H wird die Verbindung (3aS,4S,6aR)-2-Oxohexahydrothienol[3,4-d]-imidazol-4-valeriansäure bezeichnet, für die sich aber inzwischen der Trivialname Biotin durchgesetzt hat. Biotin ist in den erfindungsgemäß verwendeten Mitteln bevorzugt in Mengen von 0,0001 bis 1,0 Gew.-%, insbesondere in Mengen von 0,001 bis 0,01 Gew.-% enthalten.

The compounds of the vitamin B group mentioned are preferably contained in the agents according to the invention in amounts of 0.01-2% by weight, based on the total agent. Amounts of 0.03-1 wt .-% are particularly preferred.

• Vitamin C (ascorbic acid). Vitamin C is used in the compositions according to the invention preferably in amounts of 0.01 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
• Vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents used according to the invention in amounts of 0.01-1% by weight, based on the total agent ,
• Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
• Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] -imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile become established. Biotin is contained in the agents used according to the invention preferably in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.

Prefers the agents according to the invention contain vitamins, Provitamins and vitamin precursors from groups A, B, E and H. Of course, also several vitamins and vitamin precursors at the same time.

When Protein hydrolyzates in the context of the invention become protein hydrolysates and / or amino acids and their derivatives (H). Protein hydrolysates are product mixtures that are acidic, basic or enzymatically catalyzed degradation of proteins (proteins) to be obtained. The term protein hydrolyzates according to the invention also Total hydrolyzates and individual amino acids and their derivatives as well as mixtures of different amino acids understood. Furthermore, according to the invention from amino acids and amino acid derivatives built-up polymers under the term Understood protein hydrolysates. For example, the latter are Polyalanine, polyasparagine, polyserine, etc. Further Examples of usable according to the invention Compounds are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride. Of course can according to the invention also β-amino acids and their derivatives such as β-alanine, anthranilic acid or hippuric acid. The molecular weight of the Protein hydrolysates which can be used according to the invention is between 75, the molecular weight of glycine, and 200,000, preferably, the molecular weight is 75 to 50,000 and quite more preferably 75 to 20,000 daltons.

According to the invention Protein hydrolyzates both vegetable and animal or marine or synthetic origin.

Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts. Such products are, for example, under the trademarks Dehylan ^® (Cognis), Promois® ^® (Interorgana) Collapuron ^® (Cognis), Nutrilan® ^® (Cognis), Gelita-Sol ^® (German Gelatinefabriken Stoess & Co), Lexein ^® (Inolex) and kerasol tm ^® (Croda) sold.

Preferred according to the invention are the protein hydrolysates of plant origin, eg. Soybean, almond, pea, potato, rice and wheat protein hydrolysates. Such products are, for example, under the trademarks Gluadin ^® (Cognis), diamine ^® (Diamalt) ^® (Inolex), Hydrosog ^® (Croda), hydro Lupine ^® (Croda), hydro Sesame ^® (Croda), Hydro tritium ^® (Croda) and Crotein ^® (Croda) available.

Although the use of the protein hydrolysates is preferred as such, amino acid mixtures obtained otherwise may optionally be used instead. Also possible is the use of derivatives of protein hydrolysates, for example in the form of their fatty acid condensation products. Such products are sold, for example, under the names Lamepon® ^® (Cognis), Lexein ^® (Inolex), Crolastin ^® (Croda) or crotein ^® (Croda).

The Protein hydrolysates or their derivatives are in the inventive Agents preferably in amounts of 0.005 to 10 wt .-%, based on the entire remedy, included. Amounts of 0.01 to 5 wt .-% are special prefers.

In a further preferred embodiment of the invention contain the means of support according to the invention the effect of the invention further at least a "benefit agent" that will be selected may consist of antidandruff agents other than B) preservatives, UV filters, vegetable, animal, mineral and synthetic oils, Thickeners, polymers, humectants, hair structurants, Hair care preparations, hair restorers and hair loss preparations.

From particular advantage of the invention is when the anti-dandruff agent contain at least one constituent from the group selected is made from vegetable oils, silicones, fatty acids, Fatty alcohols, amino acids and / or derivatives thereof, plant extracts, cationic polymers other than C), cationic Surfactants and hair structurants.

The benefit agents and their preferred amounts are described below:
Preservatives which are suitable according to the invention are selected from the group formed from benzoic acid, propionic acid, salicylic acid and / or sorbic acid, and from the cosmetically acceptable salts and esters of these acids, from formaldehyl and / or paraformaldehyde, from benzyl alcohol, Germall, Dowicil, Kathon, Baypival, methylisothiazolines, quaternary ammonium compounds, alcohols and / or from essential oils such as tea tree oil, cineole, eugenol, geraniol, limonene, menthol and / or thymol.

They are the compositions of the invention - based on their total weight - in egg ner amount of 0.01 to 5 wt .-%, preferably in an amount of 0.05 to 3 wt .-% and in particular in an amount of 0.1 to 2 wt .-% added.

Completely according to the invention particularly preferred preservatives are benzoic acid, Salicylic acid and / or a cosmetically acceptable Salt or a cosmetically acceptable ester of these acids, Benzyl alcohol, dowicil, kathon, baypival, methylisothiazolines as well Mixtures of these substances.

suitable Anti-dandruff agents which differ from B) are those according to the invention Compositions in an amount of 0.05 to 5 wt .-%, preferably from 0.1 to 3.0% by weight, and more preferably from 0.3 to 2.0% by weight (relative to the total mean) and are selected from Piroctone Olamine, climbazole, ketoconazole, salicylic acid, Sulfur, selenium sulfide, tar preparations, undecenoic acid derivatives, Burdock root extracts, poplar extracts, stinging nettle extracts, walnut shell extracts, Birch extracts, willow bark extracts, rosemary extracts and / or Arnica extracts.

According to the invention preferred Salicylic Acid, Climbazole and Piroctone Olamine.

Farther may in a preferred embodiment of the invention an agent according to the invention also UV filter (I) contain. The invention to be used UV filters are subject to structural and physical considerations Features no general restrictions. Much more All UV filters that can be used in the cosmetics sector are suitable Absorption maximum in UVA (315-400 nm) -, in UVB (280-315 nm) - or in the UVC (<280 nm) range. UV filter with an absorption maximum in the UVB range, especially in the range of about 280 to about 300 nm, are particularly prefers.

The According to the invention used UV filter for example, be selected from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic esters, Cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters.

Examples of UV filters which can be used according to the invention are 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline-methylsulfate, 3,3,5-trimethyl-cyclohexylsalicylate (homosalates), 2-hydroxy-4-methoxy-benzophenone (benzophenone-3; Uvinul ^® M 40, Uvasorb MET ^{®, ®} Neo Heliopan BB, Eusolex ^® 4360), 2-phenylbenzimidazole-5-sulfonic acid and potassium, sodium and triethanolamine salts ( Phenylbenzimidazole Sulfonic Acid; Parsol ^® HS; Neo Heliopan Hydro ^®), 3,3- (1,4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1-yl methane-sulfonic acid) and salts thereof, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) Methoxydibenzoylmethane -propane-1,3-dione (butyl; Parsol ^® 1789 Eusolex ^® 9020), α- (2-oxoborn-3-ylidene) toluene-4-sulfonic acid and salts thereof, ethoxylated 4-aminobenzoic acid ethyl ester (PEG-25 PABA; Uvinul ^® P 25), 4-dimethylaminobenzoic acid 2-ethylhexyl (octyl dimethyl PABA; Uvasorb ^® DMO, Escalol ^® 507, Eusolex ^® 6007), salicylic acid-2-ethylhexyl ester (octyl salicylate; Escalol ^® 587, Neo Heliopan ^® OS, Uvinul ^® O18), 4-methoxycinnamic acid isopentyl (isoamyl p-methoxycinnamate; Neo Heliopan ^® E 1000), 4-methoxycinnamic acid 2-ethylhexyl ester (Octyl Methoxycinnamate; Parsol ^® MCX, Escalol ^® 557, Neo Heliopan AV ^®), 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt (Benzophenone-4; Uvinul ^® MS 40; Uvasorb S5 ^®), 3- (4'-methylbenzylidene) -D, L camphor (4-methylbenzylidene camphor; Parsol ^® 5000, Eusolex ^® 6300), 3-benzylidene camphor (3-benzylidene camphor), 4-isopropylbenzyl, 2,4,6-trianilino- (p-carbo-2'-ethylhexyl -1'-oxi) -1,3,5-triazine, 3-imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2-oxoborn-3-ylidenemethyl] benzyl} -acrylamids, 2,4-dihydroxy (benzophenone-1; Uvasorb ^® 20 H, Uvinul ^® 400), 1,1'-Diphenylacrylonitrilsäure-2-ethylhexyl ester (Octocrylene; Eusolex ^® OCR, Neo Heliopan ^® Type 303, Uvinul ^® N 539 SG), o-aminobenzoic acid menthyl ester (menthyl anthranilate; Neo Hel iopan ^® MA), 2,2 ', 4,4'-tetrahydroxy benzophenone (benzophenone-2; Uvinul ^® D-50), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone (Benzophenone-6), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone-5-sodium sulfonate, and 2-cyano-3, 3-diphenylacrylate 2'-ethylhexyl acrylate. Preference is given to 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, 3,3,5-trimethylcyclohexyl salicylate, 2-hydroxy-4-methoxybenzophenone , 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 3,3 '- (1,4-phenylenedimethylene) bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept -1-yl-methanesulfonic acid) and its salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, α- (2-oxoborn-3-ylidene ) -toluene-4-sulfonic acid and its salts, ethoxylated 4-aminobenzoic acid ethyl ester, 2-ethylhexyl 4-dimethylaminobenzoate, 2-ethylhexyl salicylate, isopentyl 4-methoxycinnamate, 2-ethylhexyl 4-methoxycinnamate, 2- Hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt, 3- (4'-methylbenzylidene) -D, L-camphor, 3-benzylidene-camphor, 4-isopropylbenzyl salicylate, 2,4,6-trianilino- (p-carbo 2'-ethylhexyl-1'-oxi) -1,3,5-triazine, 3-imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2-o xoborn-3-ylidenemethyl] benzyl} acrylamide. 2-Hydroxy-4-methoxy-benzophenone, 2-phenylbenzimidazole-5-sulfonic acid and their potassium, sodium and triethanolamine are very particularly preferred according to the invention salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, 4-methoxycinnamic acid 2-ethylhexyl ester and 3- (4'-methylbenzylidene) -D, L-camphor.

Prefers are those UV filters whose molar extinction coefficient at the absorption maximum above 15,000, especially above 20,000.

Farther was found to be structurally similar to UV filters in many cases, the water-insoluble compound in the context of the teaching of the invention, the higher Effect against such water-soluble compounds which differs from it by one or more additional distinguish ionic groups. As water insoluble in the context of the invention, those UV filters to be understood at 20 ° C to not more than 1 wt .-%, especially not to more than 0.1 wt .-%, dissolve in water. Furthermore, these should Compounds in common cosmetic oil components at room temperature to at least 0.1, in particular at least 1 wt .-% be soluble). The use of water-insoluble UV filter can therefore be preferred according to the invention be.

According to one Another embodiment of the invention are those UV filters preferably a cationic group, in particular a quaternary Ammonium group.

These UV filters have the general structure U-Q.

Of the Structural part U stands for a UV-absorbing radiation Group. This group can in principle be distinguished from the known, in the Cosmetic area usable, derived above UV filters, in which a group, usually a hydrogen atom, of the UV filter by a cationic group Q, in particular with a quaternary Amino function, is replaced.

• – substituierte Benzophenone,
• – p-Aminobenzoesäureester,
• – Diphenylacrylsäureester,
• – Zimtsäureester,
• – Salicylsäureester,
• – Benzimidazole und
• – o-Aminobenzoesäureester.

Compounds from which the structural part U can derive are, for example

• Substituted benzophenones,
• P-aminobenzoic acid ester,
• - diphenylacrylic acid ester,
• - cinnamic acid ester,
• Salicylic acid ester,
• Benzimidazoles and
• O-aminobenzoic acid ester.

structural parts U, derived from cinnamic acid amide or N, N-dimethylamino-benzoic acid amide derive, are preferred according to the invention.

The Structural parts U can be chosen in principle be that the absorption maximum of the UV filters in both the UVA (315-400 nm) -, as well as in the UVB (280-315 nm) - or in the UVC (<280 nm) range can lie. UV filter with an absorption maximum in the UVB range, especially in the range of about 280 to about 300 nm, are particularly prefers.

Farther becomes the structural part U, also depending on structural part Q, preferably chosen such that the molar extinction coefficient of the UV filter at the absorption maximum above 15,000, in particular above from 20000, lies.

Of the Structural part Q preferably contains as a cationic group a quaternary ammonium group. This quaternary ammonium group can in principle be connected directly to the structural part U, so that the structural part U is one of the four substituents of the positive represents charged nitrogen atom. However, one of the four substituents on the positively charged nitrogen atom form a group, in particular an alkylene group having 2 to 6 carbon atoms, the as a connection between the structural part U and the positively charged Nitrogen atom acts.

Advantageously, the group Q has the general structure - (CH ₂ ) _x -N ⁺ R ¹ R ² R ³ X ^- , in which x is an integer from 1 to 4, R ¹ and R ² independently of one another are C _{1 -4} alkyl groups, R ³ is a C _1-22 alkyl group or a benzyl group and X ^{- is} a physiologically acceptable anion. In the context of this general structure, x preferably represents the number 3, R ¹ and R ² each represent a methyl group and R ^{3 represents} either a methyl group or a saturated or unsaturated, linear or branched hydrocarbon chain having 8 to 22, in particular 10 to 18, carbon atoms.

physiological Compatible anions are, for example, inorganic anions such as halides, especially chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, Tartrate, methosulfate and tosylate.

Two preferred UV filters with cationic groups are the commercially available compounds cinnamic acid trimethyl ammonium chloride (Incroquat ^® UV-283) and Dodecyldimethylaminobenzamidopropyl-tosylate (Escalol ^® HP 610).

Of course the teaching according to the invention also includes the use a combination of several UV filters. In the context of this embodiment is the combination of at least one water-insoluble UV filters with at least one UV filter with a cationic Group preferred.

The UV filters (I) are customary in the compositions according to the invention in amounts of 0.1-5% by weight, based on the total agent, contain. Levels of 0.4-2.5 wt .-% are preferred.

In a further preferred embodiment of the invention can the effect of the agent according to the invention by the addition of vegetable, animal, mineral and synthetic oils be optimized. Among them are fatty acids, fatty alcohols, natural and synthetic waxes, which are both solid Form as well as liquid in aqueous dispersion can exist, and natural and synthetic understand cosmetic oil components.

As fatty acids can be used linear and / or branched, saturated and / or unsaturated fatty acids with 6-30 carbon atoms. Preferred are fatty acids with 10-22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ^® 871 and Emersol ^® 875, and isopalmitic acids such as the commercial product Edenor ^® IP 95, and all other products sold under the trade names Edenor ^® (Cognis) fatty acids. Further typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic as well as their technical mixtures, the z. As in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from the Roelen oxo synthesis or the dimerization of unsaturated fatty acids. Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.

The Use amount is 0.1-15 wt .-%, based on the entire remedy. In a preferred embodiment the amount is 0.2-10 wt .-%, with very particular are advantageous amounts of 0.5-5 wt.%.

As fatty alcohols it is possible to use saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C ₆ -C ₃₀ -, preferably C ₁₀ -C ₂₂ - and very particularly preferably C ₁₂ -C ₂₂ -carbon atoms. Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character. However, the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction. Also usable according to the invention are those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols. Such substances are, for example, under the names Stenol ^® , z. B. Stenol ^® 1618 or Lanette ^®, z. B. Lanette ^® O or Lorol ^®, z. B. Lorol® ^® C8, Lorol® ^® C14, C18 Lorol® ^{®, ®} Lorol® C8-18, HD Ocenol ^®, Crodacol ^®, z. B. Crodacol CS ^{®, ®} Novol, Eutanol ^® G, Guerbitol ^® 16, Guerbitol ^® 18, Guerbitol ^® 20, Isofol ^® 12, Isofol ^® 16, Isofol ^® 24, Isofol ^® 36, Isocarb 12 ^{®, ®} Isocarb 16 or Isocarb ^® 24 for sale. Of course, wool wax alcohols, as are commercially available, for example under the names of Corona ^®, White Swan ^®, Coronet ^® or Fluilan ^® can be used according to the invention. The fatty alcohols are used in amounts of 0.1-20 wt .-%, based on the total preparation, preferably in amounts of 0.1-10 wt .-%.

As natural or synthetic waxes can be used according to the invention solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP. Such waxes are available, for example, from Kahl & Co., Trittau.

• – flüssige Paraffinöle, Isoparaffinöle und synthetische Kohlenwasserstoffe sowie Di-n-alkylether mit insgesamt zwischen 12 bis 36 C-Atomen, insbesondere 12 bis 24 C-Atomen, wie beispielsweise Di-n-octylether, Di-n-decylether, Di-n-nonylether, Di-n-undecylether, Di-n-dodecylether, n-Hexyl-n-octylether, n-Octyl-n-decylether, n-Decyl-n-undecylether, n-Undecyl-n-dodecylether und n-Hexyl-n-Undecylether sowie Di-tert-butylether, Di-iso-pentylether, Di-3-ethyldecylether, tert.-Butyl-n-octylether, iso-Pentyl-n-octylether und 2-Methyl-pentyl-n-octylether. Die als Handelsprodukte erhältlichen Verbindungen 1,3-Di-(2-ethyl-hexyl)-cyclohexan (Cetiol^® S) und Di-n-octylether (Cetiol^® OE) können bevorzugt sein.
• – Esteröle. Unter Esterölen sind zu verstehen die Ester von C₆-C₃₀-Fettsäuren mit C₂-C₃₀-Fettalkoholen. Bevorzugt sind die Monoester der Fettsäuren mit Alkoholen mit 2 bis 24 C-Atomen. Beispiele für eingesetzte Fettsäurenanteile in den Estern sind Capronsäure, Caprylsäure, 2-Ethylhexansäure, Caprinsäure, Laurinsäure, Isotridecansäure, Myristinsäure, Palmitinsäure, Palmitoleinsäure, Stearinsäure, Isostearinsäure, Ölsäure, Elaidinsäure, Petroselinsäure, Linolsäure, Linolensäure, Elaeostearinsäure, Arachinsäure, Gadoleinsäure, Behensäure und Erucasäure sowie deren technische Mischungen, die z. B. bei der Druckspaltung von natürlichen Fetten und Ölen, bei der Oxidation von Aldehyden aus der Roelen'schen Oxosynthese oder der Dimerisierung von ungesättigten Fettsäuren anfallen. Beispiele für die Fettalkoholanteile in den Esterölen sind Isopropylalkohol, Capronalkohol, Caprylalkohol, 2-Ethylhexylalkohol, Caprinalkohol, Laurylalkohol, Isotridecylalkohol, Myristylalkohol, Cetylalkohol, Palmoleylalkohol, Stearylalkohol, Isostearylalkohol, Oleylalkohol, Elaidylalkohol, Petroselinylalkohol, Linolylalkohol, Linolenylalkohol, Elaeostearylalkohol, Arachylalkohol, Gadoleylalkohol, Behenylalkohol, Erucylalkohol und Brassidylalkohol sowie deren technische Mischungen, die z. B. bei der Hochdruckhydrierung von technischen Methylestern auf Basis von Fetten und Ölen oder Aldehyden aus der Roelen'schen Oxosynthese sowie als Monomerfraktion bei der Dimerisierung von ungesättigten Fettalkoholen anfallen. Erfindungsgemäß besonders bevorzugt sind Isopropylmyristat (Rilanit^® IPM), Isononansäure-C16-18-alkylester (Cetiol^® SN), 2-Ethylhexylpalmitat (Cegesoft^® 24), Stearinsäure-2-ethylhexylester (Cetiol^® 868), Cetyloleat, Glycerintricaprylat, Kokosfettalkohol-caprinat/-caprylat (Cetiol^® LC), n-Butylstearat, Oleylerucat (Cetiol^® J 600), Isopropylpalmitat (Rilanit^® IPP), Oleyl Oleate (Cetiol^®), Laurinsäurehexylester (Cetiol^® A), Di-n-butyladipat (Cetiol^® B), Myristylmyristat (Cetiol^® MM), Cetearyl Isononanoate (Cetiol^® SN), Ölsäuredecylester (Cetiol^® V).
• – Dicarbonsäureester wie Di-n-butyladipat, Di-(2-ethylhexyl)-adipat, Di-(2-ethylhexyl)-succinat und Di-isotridecylacelaat sowie Diolester wie Ethylenglykol-dioleat, Ethylenglykol-di-isotridecanoat, Propylenglykol-di(2-ethylhexanoat), Propylenglykol-di-isostearat, Propylenglykol-di-pelargonat, Butandiol-di-isostearat, Neopentylglykoldicaprylat,
• – symmetrische, unsymmetrische oder cyclische Ester der Kohlensäure mit Fettalkoholen, beispielsweise beschrieben in der DE-OS 197 56 454 , Glycerincarbonat oder Dicaprylylcarbonat (Cetiol^® CC),
• – Mono-, Di- und Trifettsäureester von gesättigten und/oder ungesättigten linearen und/oder verzweigten Fettsäuren mit Glycerin, wie beispielsweise Monomuls^® 90-O18, Monomuls^® 90-L12 oder Cutina^® MD.

The natural and synthetic cosmetic oil bodies which can increase the action of the agent according to the invention include, for example:

• Liquid paraffin oils, isoparaffin oils and synthetic hydrocarbons and di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as, for example, di-n-octyl ether, di-n-decyl ether, di-n- nonyl ether, di-n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl n-undecyl ether and di-tert-butyl ether, di-iso-pentyl ether, di-3-ethyldecyl ether, tert-butyl n-octyl ether, iso-pentyl n-octyl ether and 2-methyl-pentyl-n-octyl ether. The compounds are available as commercial products 1,3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ^® S), and di-n-octyl ether (Cetiol ^® OE) may be preferred.
• - Ester oils. Ester oils are understood as meaning the esters of C ₆ -C ₃₀ -fatty acids with C ₂ -C ₃₀ -fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred. Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and their technical mixtures, the z. As in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from the Roelen oxo synthesis or the dimerization of unsaturated fatty acids. Examples of the fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures, the z. B. incurred in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from the Roelen oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols. According to the invention, particularly preferred are isopropyl myristate (IPM Rilanit ^®), isononanoic acid C16-18 alkyl ester (Cetiol ^® SN), 2-ethylhexyl palmitate (Cegesoft ^® 24), stearic acid-2-ethylhexyl ester (Cetiol ^® 868), cetyl oleate, glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ^® LC), n-butyl stearate, oleyl erucate (Cetiol ^® J 600), isopropyl palmitate (IPP Rilanit ^®), oleyl Oleate (Cetiol ^®), hexyl laurate (Cetiol ^® A), di-n-butyl adipate (Cetiol ^® B), myristyl myristate (Cetiol ^® MM), cetearyl isononanoate (Cetiol ^® SN), oleic acid decyl ester (Cetiol ^® V).
• Dicarboxylic acid esters such as di-n-butyl adipate, di (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate, and diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2 ethylhexanoate), propylene glycol diisostearate, propylene glycol di-pelargonate, butanediol diisostearate, neopentyl glycol dicaprylate,
• Symmetrical, unsymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example described in US Pat DE-OS 197 56 454 , Glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC),
• - mono-, di- and trifatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol such as ^® Monomuls 90-O18, Monomuls 90-L12 ^® or Cutina ^® MD.

The Amount used is - based on the total Average - 0.1-50% by weight, preferably 0.1-20% by weight and more preferably 0.1-15% by weight.

When natural oils come for example amaranth seed oil, Apricot kernel oil, argan oil, avocado oil, babassu oil, Cottonseed oil, borage seed oil, camelina oil, Thistle oil, peanut oil, pomegranate seed oil, Grapefruit seed oil, hemp oil, rosehip seed oil, Hazelnut oil, elderflower seed oil, currant seed oil, Jojoba oil, cocoa butter, linseed oil, macadamia nut oil, Corn oil, almond oil, marula oil, evening primrose oil, Olive oil, palm oil, peach kernel oil, rapeseed oil, Reisbi, sea buckthorn pulp oil, sea buckthorn kernel oil, Sesame oil, shea butter, soybean oil, sunflower oil, Grapeseed oil, walnut oil or wild rose oil in question.

Apricot kernel oil, Rose hip kernel oil, jojoba oil, almond oil, Olive oil, argan oil, amaranth seed oil, shea butter and cocoa butter are particularly preferred in the invention to count preferred natural oil components.

The Vegetable oils are used in the invention Resources - in relation to the total weight of funds - in from 0.001 to 10% by weight, preferably from 0.005 to 7% by weight, particularly preferably from 0.01 to 5% by weight and in particular from 0.05 used to 3 wt .-%.

When Furthermore, it has been found to be advantageous if polymers are used in the inventive agents are included. In a preferred embodiments are those used in the invention Therefore, polymers have been added, whereby both cationic, anionic, amphoteric and nonionic polymers as effective have proven.

polymers have in the compositions of the invention several functions. On the one hand serve in particular cationic polymers in cosmetic compositions (and the compositions according to the invention can serve as a cosmetic composition) as a conditioner for the skin and hair. Cationic polymers serve but also as a deposition aid for fats, waxes and oils, as well as for silicones.

Farther have polymers film-forming properties and often thickening Properties, why their use in compositions in which the viscosity stability is a big one Role plays, is also preferred.

Especially preference is given to the use of cationic polymers which differ from the Polymers C) differ. They become the invention Compositions - based on their total weight - in one Amount of 0.01 to 5 wt .-%, preferably from 0.02 to 3 and in particular from 0.05 to 2% by weight.

Cationic polymers which are suitable according to the invention are polymers which have groups in the main and / or side chain which may be "temporary" or "permanent" cationic. According to the invention, "permanently cationic" refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups. In particular, those polymers in which the quaternary ammonium group is bonded via a C _1-4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.

in der R¹⁸ = -H oder -CH₃ ist, R¹⁹, R²⁰ und R²¹ unabhängig voneinander ausgewählt sind aus C_1-4-Alkyl-, -Alkenyl- oder -Hydroxyalkylgruppen, m = 1, 2, 3 oder 4, n eine natürliche Zahl und X^– ein physiologisch verträgliches organisches oder anorganisches Anion ist, sowie Copolymere, bestehend im wesentlichen aus den in Formel (III) aufgeführten Monomereinheiten sowie nichtionogenen Monomereinheiten, sind besonders bevorzugte kationische Polymere. Im Rahmen dieser Polymere sind diejenigen erfindungsgemäß bevorzugt, für die mindestens eine der folgenden Bedingungen gilt:

• – R¹⁸ steht für eine Methylgruppe
• – R¹⁹, R²⁰ und R²¹ stehen für Methylgruppen
• – m hat den Wert 2.

Homopolymers of the general formula (PI),

wherein R ^{18 is} -H or -CH ₃ , R ¹⁹ , R ²⁰ and R ^{21 are} independently selected from C _1-4 alkyl, alkenyl or hydroxyalkyl groups, m = 1, 2, 3 or 4 , n is a natural number and X ^{- is} a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (III) and nonionic monomer units, are particularly preferred cationic polymers. In the context of these polymers, preference is given to those according to the invention for which at least one of the following conditions applies:

• - R ¹⁸ is a methyl group
• - R ¹⁹ , R ²⁰ and R ²¹ are methyl groups
• - m has the value 2.

Suitable physiologically tolerated counterions X ^- include, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preference is given to halide ions, in particular chloride.

One particularly suitable homopolymer is, if desired crosslinked, poly (methacryloyloxyethyltrimethylammoniumchlorid) with the INCI name Polyquaternium-37. (Building block Synthalen - not normal required)

The If desired, crosslinking can be carried out using olefinic polyols unsaturated compounds, for example divinylbenzene, Tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ether, or Allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, Arabitol, mannitol, sorbitol, sucrose or glucose. methylenebisacrylamide is a preferred crosslinking agent.

The homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight. Such polymer dispersions are (under the names Salcare ^® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ^® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol (with a mixture of caprylic and capric acid INCI name: propylene glycol Dicaprylate / Dicaprate) and Tridecylpolyoxypropylen polyoxyethylene ether (INCI name : PPG-1-trideceth-6)) are commercially available.

Copolymers with monomer units of the formula (PI) contain as nonionic monomer units preferably acrylamide, methacrylamide, acrylic acid-C _1-4 -alkyl esters and methacrylic acid-C _1-4 -alkyl esters. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ^® SC.

• – quaternisierte Cellulose-Derivate, wie sie unter den Bezeichnungen Celquat^® und Polymer JR^® im Handel erhältlich sind. Die Verbindungen Celquat^® H 100, Celquat^® L 200 und Polymer JR^® 400 sind bevorzugte quaternierte Cellulose-Derivate,
• – hydrophob modifizierte kationische Polymere, wie sie beispielsweise unter der Handelbezeichnung SoftCat^® und Polymer^® SL im Handel erhältlich sind
• – kationische Alkylpolyglycoside,
• – kationisierter Honig, beispielsweise das Handelsprodukt Honeyquat^® 50,
• – Polysiloxane mit quaternären Gruppen, wie beispielsweise die im Handel erhältlichen Produkte Q2-7224 (Hersteller: Dow Corning; ein stabilisiertes Trimethylsilylamodimethicon), Dow Corning^® 929 Emulsion (enthaltend ein hydroxyl-amino-modifiziertes Silicon, das auch als Amodimethicone bezeichnet wird), SM-2059 (Hersteller: General Electric), SLM-55067 (Hersteller: Wacker) sowie Abil^®-Quat 3270 und 3272 (Hersteller: Th. Goldschmidt; diquaternäre Polydimethylsiloxane, Quaternium-80),
• – polymere Dimethyldiallylammoniumsalze und deren Copolymere mit Estern und Amiden von Acrylsäure und Methacrylsäure. Die unter den Bezeichnungen Merquat^® 100 (Poly(dimethyldiallylammoniumchlorid)) und Merquat^® 550 (Dimethyldiallylammoniumchlorid-Acrylamid-Copolymer) im Handel erhältlichen Produkte sind Beispiele für solche kationischen Polymere,
• – Copolymere des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylaminoalkylacrylats und -methacrylats, wie beispielsweise mit Diethylsulfat quaternierte Vinylpyrrolidon-Dimethylaminoethylmethacrylat-Copolymere. Solche Verbindungen sind unter den Bezeichnungen Gafquat^® 734 und Gafquat^® 755 im Handel erhältlich,
• – Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymere, wie sie unter den Bezeichnungen Luviquat^® FC 370, FC 550, FC 905 und HM 552 angeboten werden.
• – quaternierter Polyvinylalkohol, sowie die unter den Bezeichnungen
• – Polyquaternium 2,
• – Polyquaternium 17,
• – Polyquaternium 18 und
• Polyquaternium 27 bekannten Polymeren mit quartären Stickstoffatomen in der Polymerhauptkette.

Further, particularly preferred cationic polymers are, for example

• - Quaternized cellulose derivatives, such as those under the names Celquat ^® and Polymer JR ^® commercially available. The compounds Celquat ^® H 100, Celquat L 200 and Polymer JR ^{® ®} 400 are preferred quaternized cellulose derivatives
• - hydrophobically modified cationic polymers, such as are obtainable, for example, under the trade designation SOFTCAT ^® and Polymer SL ^® commercially
• Cationic alkyl polyglycosides,
• - cationized honey, for example the commercial product Honeyquat ^® 50,
• Quaternary group polysiloxanes, such as the commercially available products Q2-7224 (manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone), Dow ^Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicones), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ^® quat 3270 and 3272 (manufacturer: Th Goldschmidt; diquaternary polydimethylsiloxanes, quaternium-80).,
• - Dimethyldiallylammoniumsalze polymeric and their copolymers with esters and amides of acrylic acid and methacrylic acid. Under the names Merquat ^® 100 (Poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) are examples of such cationic polymers,
• - Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ^® 734 and Gafquat ^® 755 commercially,
• - Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers, such as those under the names Luviquat ^® FC 370, FC 550, FC 905 and HM 552 are offered.
• - Quaternized polyvinyl alcohol, as well as those under the names
• - Polyquaternium 2,
• - Polyquaternium 17,
• - Polyquaternium 18 and
• Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain.

Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ^® LM 200), known polymers. , Gaffix ^® VC 713 (manufactured by ISP): Also according to the invention can be used the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ^® ASCP 1011, Gafquat ^® HS 110, Luviquat ^® 8155 and Luviquat ^® MS 370 available are.

Further cationic polymers according to the invention are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic. For example, chitosan and its derivatives are preferred as Hydagen CMF ^®, Hydagen HCMF ^®, Kytamer ^® PC and Chitolam ^® NB / 101 are freely available commercially, for example under the trade names. Chitosans are deacetylated chitins, which are commercially available in different degrees of deacetylation and different degrees of degradation (molecular weights). Their preparation is z. In DE 44 40 625 A1 and in DE 1 95 03 465 A1 described.

Particularly suitable chitosans have a degree of deacetylation of at least 80% and a molecular weight of 5 × 10 ⁵ to 5 × 10 ⁶ (g / mol).

to Preparation of preparations according to the invention must be Chitosan be converted into the salt form. This can by dissolving in dilute aqueous Acids take place. As acids are both mineral acids such as Hydrochloric acid, sulfuric acid and phosphoric acid as well as organic acids, eg. B. low molecular weight carboxylic acids, Polycarboxylic acids and hydroxycarboxylic acids suitable. Furthermore, higher molecular weight alkyl sulfonic acids or alkyl sulfuric acids or organophosphoric acids used, as far as these are the required physiological Have compatibility. Suitable acids for transfer of chitosan in the salt form are z. Acetic acid, glycolic acid, Tartaric acid, malic acid, citric acid, Lactic acid, 2-pyrrolidinone-5-carboxylic acid, benzoic acid or salicylic acid. Preference is given to low molecular weight hydroxycarboxylic acids such as As glycolic acid or lactic acid used.

According to the invention particularly preferred, different from c), cationic polymers are those available under the names Celquat ^® and Polymer JR ^® commercially quaternized cellulose derivatives (Polyquaternium-10 and Polyquaternium-4).

Corresponding commercial products are, among others available under the names Polymer JR ^® 400, Celquat ^® H 100 and Celquat ^® 1200th

Furthermore, cationized protein hydrolyzates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. The protein hydrolyzates on which the cationic derivatives according to the invention are based can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis. The hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof. The quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides. Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of the cationic protein hydrolyzates and derivatives according to the invention, those mentioned under the INCI names in "International Cosmetic Ingredient Dictionary and Handbook," (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, suite 300, Washington, DC 20036-4702) Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein, Hydroxypropyltrimonium Hydrolyzed Keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein , Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Laurdimonium Hydroxyprop yl Hydrolyzed Soy Protein, Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein, Laurydimium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimonium Hydroxypropyl Hydrolyzed Casein, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Keratin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimonium Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium-79 Hydrolyzed Soy Protein, Quaternium-79 Hydrolyzed Wheat Protein.

Very particular preference is given to the cationic protein hydrolysates and derivatives on plant Ba sis. They are also regarded as "hair structureants" and are therefore preferred in the compositions according to the invention in amounts of from 0.001 to 10% by weight, preferably in amounts of from 0.005 to 5% by weight and in particular in amounts of from 0.01 to 3% by weight. % (based on the total weight of funds).

Farther are the provitamins panthenol and pantolactone, the vitamin derivative Niacinamide and the active ingredients arginine, acetyl tyrosine and sericin to count to the "hair structure". Their use in compositions according to the invention, which are formulated as cosmetic hair treatment products, also preferred. The individual substances become later Site of the application described in more detail.

It may also be advantageous if the inventive Agent in addition to the cationic polymers more natural and / or synthetic polymers which are anionic or amphoteric as well as non-ionic.

at The anionic polymers are usually an anionic polymer, which carboxylate and / or sulfonate groups exhibit. Examples of anionic monomers from which such polymers may be acrylic acid, Methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. It can the acidic groups in whole or in part as sodium, potassium, ammonium, Mono- or triethanolammonium salt present. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.

When anionic polymers have proven to be particularly effective as the sole or co-monomer 2-acrylamido-2-methylpropanesulfonic acid contain, wherein the sulfonic acid group completely or partially as sodium, potassium, ammonium, mono- or triethanolammonium salt may be present.

More preferably, the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid, which is available for example under the name Rheothik ^® 11-80 is commercially.

Within In this embodiment, it may be preferable to use copolymers from at least one anionic monomer and at least one nonionic Use monomer. Regarding the anionic monomers Reference is made to the substances listed above. preferred non-ionic monomers are acrylamide, methacrylamide, acrylic esters, Methacrylic acid esters, vinylpyrrolidone, vinyl ethers and vinyl esters.

Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. A particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used. Such a polymer is contained in the commercial product urchins ^® 305 from SEPPIC. The use of this compound, which in addition to the polymer component contains a hydrocarbon mixture (C ₁₃ -C ₁₄ isoparaffin) and a nonionic emulsifier (laureth-7), has proved to be particularly advantageous within the scope of the teaching according to the invention.

Also sold under the name Simulgel ^® 600 as a compound with isohexadecane and polysorbate-80 Natriumacryloyldimethyltaurat copolymers have proved to be particularly effective according to the invention.

Also preferred for ionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ^® commercially.

Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers. A 1.9-decadienes crosslinked maleic acid-methyl copolymer available under the name Stabileze® ^® QM.

Furthermore, amphoteric polymers can be used as constituents as polymers for increasing the action of the agent according to the invention. The term amphoteric polymers includes both those polymers which contain in the molecule both free amino groups and free -COOH or SO ₃ H groups and are capable of forming internal salts, as well as zwitterionic polymers which in the molecule have quaternary ammonium groups and -COO ^- or -SO ₃ groups, and such polymers summarized, the -COOH or SO ₃ H groups and quaternary ammonium groups.

An example of the present invention amphopolymer suitable is the acrylic resin commercially available as Amphomer ^® is a copolymer of tert-butylaminoethyl methacrylate, N- (1,1,3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group of acrylic acid, Represents methacrylic acid and its simple esters.

• (a) Monomeren mit quartären Ammoniumgruppen der allgemeinen Formel (PII), R²²-CH=CR²³-CO-Z-(C_nH_2n)-N⁽⁺⁾R²⁴R²⁵R²⁶A^(–) (PII)in der R²² und R²³ unabhängig voneinander stehen für Wasserstoff oder eine Methylgruppe und R²⁴, R²⁵ und R²⁶ unabhängig voneinander für Alkylgruppen mit 1 bis 4 Kohlenstoff-Atomen, Z eine NH-Gruppe oder ein Sauerstoffatom, n eine ganze Zahl von 2 bis 5 und das Anion einer organischen oder anorganischen Säure ist und
• (b) monomeren Carbonsäuren der allgemeinen Formel (PIII), R²⁷-CH=CR²⁸-COOH (PIII)in denen R²⁷ und R²⁸ unabhängig voneinander Wasserstoff oder Methylgruppen sind.

Preferably usable amphoteric polymers are those polymers which are composed essentially

• (a) monomers having quaternary ammonium groups of the general formula (PII), R ²² -CH = CR ²³ -CO-Z- (C _n H _2n ) -N ⁽⁺⁾ R ²⁴ R ²⁵ R ²⁶ A ^(-) (PII) in which R ²² and R ²³ independently of one another are hydrogen or a methyl group and R ²⁴ , R ²⁵ and R ²⁶ are each independently alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer from 2 to 5 and the anion of an organic or inorganic acid is and
• (b) monomeric carboxylic acids of the general formula (PIII), R ²⁷ -CH = CR ²⁸ -COOH (PIII) in which R ²⁷ and R ^{28 are} independently hydrogen or methyl groups.

These compounds can be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention. With regard to the details of the preparation of these polymers is expressly based on the content of German patent application 39 29 973 Referenced. Very particular preference is given to those polymers in which monomers of the type (a) are used in which R ²⁴ , R ²⁵ and R ^{26 are} methyl groups, Z is an NH group and A ^{(-) is} a halide, methoxysulfate or ethoxy sulfate Ion is; Acrylamidopropyl trimethyl ammonium chloride is a particularly preferred monomer (a). Acrylic acid is preferably used as monomer (b) for the stated polymers.

• – Vinylpyrrolidon/Vinylester-Copolymere, wie sie beispielsweise unter dem Warenzeichen Luviskol^® (BASF) vertrieben werden. Luviskol^® VA 64 und Luviskol^® VA 73, jeweils Vinylpyrrolidon/Vinylacetat-Copolymere, sind ebenfalls bevorzugte nichtionische Polymere.
• – Celluloseether, wie Hydroxypropylcellulose, Hydroxyethylcellulose und Methylhydroxypropylcellulose, wie sie beispielsweise unter den Warenzeichen Culminal^® und Benecel^® (AQUALON) vertrieben werden.
• – Schellack
• – Polyvinylpyrrolidone, wie sie beispielsweise unter der Bezeichnung Luviskol^® (BASF) vertrieben werden.
• – Siloxane. Diese Siloxane können sowohl wasserlöslich als auch wasserunlöslich sein. Geeignet sind sowohl flüchtige als auch nichtflüchtige Siloxane, wobei als nichtflüchtige Siloxane solche Verbindungen verstanden werden, deren Siedepunkt bei Normaldruck oberhalb von 200°C liegt. Bevorzugte Siloxane sind Polydialkylsiloxane, wie beispielsweise Polydimethylsiloxan, Polyalkylarylsiloxane, wie beispielsweise Polyphenylmethylsiloxan, ethoxylierte Polydialkylsiloxane sowie Polydialkylsiloxane, die Amin- und/oder Hydroxy-Gruppen enthalten.
• – Glycosidisch substituierte Silicone.

Suitable nonionic polymers according to the invention are:

• - Vinylpyrrolidone / vinyl ester copolymers, such as those sold under the trademark Luviskol ^® (BASF). Luviskol ^® VA 64 and Luviskol ^® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
• - cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and methylhydroxypropyl cellulose, as for example under the trademark Culminal® ^® and Benecel ^® (AQUALON).
• - shellac
• - polyvinylpyrrolidones, as for example under the name Luviskol ^® (BASF).
• - siloxanes. These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure. Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups.
• - Glycosidically substituted silicones.

It According to the invention it is also possible that several, in particular two different polymers of the same charge and / or in each case an ionic and an amphoteric and / or not ionic polymer can be used simultaneously.

Of the Use of the further polymers in amounts of from 0.01 to 10% by weight, based on the total agent, is preferred according to the invention. Amounts of from 0.1 to 5% by weight, in particular from 0.1 to 3% by weight, are particularly preferred.

In addition, it may prove advantageous to add in the compositions according to the invention humectants or penetration aids and / or swelling agents (M). These excipients provide better penetration of active ingredients into the keratin fiber or help the keratin fiber swell. These include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, lactic acid, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example propylene glycol monoethyl ether, carbonates, Hydrogencarbonates, diols and triols, and in particular 1,2-diols and 1,3-diols such as 1,2-propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-dodecanediol, 1,3-propanediol , 1,6-hexanediol, 1,5-pentanediol, 1,4-butanediol.

Particularly according to the invention suitable are lactic acid and glycerol.

The Humectants are used in the inventive Compositions - based on the total composition - in Amounts from 0.01 to 10 wt .-%, preferably in amounts of 0.05 to 5 wt .-% and in particular in amounts of 0.1 to 3 wt .-% used.

The compositions according to the invention may contain, in addition to the ingredients mentioned above and optional further ingredients, other substances which prevent, alleviate or cure hair loss. In particular, a content of hair root stabilizing agents is advantageous. These substances are described below:
Propecia (Finasteride) is currently the only preparation that is approved worldwide and has been proven in many studies to be effective and tolerable. Propecia causes less DHT to be produced from testosterone.

minoxidil is probably the oldest with or without supplementary additives proven hair restorer. For the treatment of hair loss it may only be used for external application. There are hair lotions that contain 2% -5% minoxidil, as well Gels with up to 15% minoxidil. The effectiveness decreases with the dosage to, in hair waters Minoxidil but only up to 5% proportion is soluble. In many countries, hair tonic is minoxidil content up to 2% available without prescription.

to Combat hormonal influences on hair follicles can be used for external application spironolactone in the form of hair tonic and in combination with minoxidil. Spironolactone acts as an androgen receptor blocker, ie. the connection of DHT to the hair follicles is prevented.

In summary hair treatment compositions according to the invention are preferred, the additional - based on its weight - 0.001 up to 5% by weight hair root stabilizing substances, in particular minoxidil and / or finasteride and / or ketoconazole.

When another ingredient can the inventive Agent with particular preference one or more amino acids or their physiologically tolerated derivatives, since these substances also serve as "hair structuring agents", and their use therewith in compositions according to the invention, which are formulated as a cosmetic hair conditioner, extremely is preferred. Particularly preferred according to the invention usable amino acids or amino acid derivatives are from the group glycine, alanine, valine, leucine, isoleucine, Phenylalanine, tyrosine, tryptophan, proline, aspartic acid, Glutamic acid, asparagine, glutamine, serine, threonine, cysteine, Methionine, lysine, arginine, histidine, β-alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine sulfoxide (L-alliin), L-trans-4-hydroxyproline, L-5-oxoproline (L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, both the individual amino acids and / or their derivatives as well their mixtures can be used.

preferred Compositions according to the invention contain one or more Amino acids or their derivatives in narrower ranges. Here are preferred compositions according to the invention characterized in that they relate as a care substance on their weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0.05 to 1.5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% Amino acid (s) / - derivatives, preferably from the group glycine and / or alanine and / or valine and / or lysine and / or leucine and / or Threonine and / or arginine and / or acetyl tyrosine included.

A another group of preferred components in the inventive Funds in the event that they are used as a cosmetic hair treatment are the hair products. Count among them the already mentioned vegetable oils, Panthenol, Hydrogenated Jojoba Oil, biotin and allantoin, but also the plant extracts.

Usually These extracts are produced by extraction of the whole plant. However, it may also be preferred in individual cases, the Extracts of flowers and / or leaves only to produce the plant.

Regarding the plant extracts usable according to the invention particular attention is drawn to the extracts mentioned in the page 44 of the 3rd edition of the guideline for the ingredient declaration of cosmetic Medium, published by the Industrieverband Körperpflege- and detergent e. V. (IKW), Frankfurt, beginning table are.

According to the invention especially the extracts of green tea, oak bark, stinging nettle, Witch hazel, hops, henna, chamomile, burdock root, horsetail, Hawthorn, lime blossom, almond, aloe vera, spruce needle, Horse chestnut, sandalwood, juniper, coconut, mango, apricot, Lime, Wheat, Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Meadowfoam, Quendel, Yarrow, Thyme, Melissa, Toadstool, coltsfoot, marshmallow, meristem, ginseng and ginger root prefers.

Especially preferred are the extracts of green tea, oak bark, Stinging nettle, witch hazel, hops, chamomile, burdock root, horsetail, Lime blossom, almond, aloe vera, coconut, mango, apricot, lime, Wheat, kiwi, melon, orange, grapefruit, sage, rosemary, birch, Meadowfoam, Quendel, Yarrow, Hauhechel, Meristem, Ginseng and ginger root.

When Extraction agent for the preparation of said plant extracts may be used water, alcohols and mixtures thereof become. Among the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as the sole extractant also in mixture with water, preferred. Plant extracts based of water / propylene glycol in the ratio 1:10 to 10: 1 proved to be particularly suitable.

The Plant extracts can according to the invention both be used in pure as well as in diluted form. If used in diluted form, contain they usually about 2-80 wt .-% of active substance and as a solvent used in their extraction Extracting agent or extractant mixture.

Farther it may be preferred in the inventive Mixtures of several, especially two, different Use plant extracts.

Prefers are also extracts of Echinacea or Moringa plants, with Echinacea extracts are particularly preferred. The genus of the sun hat family (Echinaceae) includes North American perennials, some of which for a long time for the supportive treatment of infections (inside) and wounds (externally) are used. Echinacea extracts are known to stimulate of the immune system and as an antimicrobial and antiviral substance used

The Plant extracts from plants of the genus Echinacea can from different sun hat plants (Echinacea, synonym: Brauneria NECKER), in particular from Echinacea angustifolia DC, Echinacea paradoxa (NORTON), Echinacea simulata, E. atrorubens, E. tennesiensis, Echinacea strigosa (MCGREGOR), Echinacea laevigata, Echinacea purpurea (L.) Moench and Echinacea pallida (Nutt), as well as from these extracts to be recovered active substances. Especially preferred become extracts of Sonnenhutgewächsen, in particular of Echinacea purpurea (L) MOENCH.

Prefers extracts of herb (aboveground parts of plants) and / or root of the sun hat family. The extracts Can be used with water, as well as polar or non-polar organic Solvents and mixtures thereof known in the art Be made way. Extracts by extraction with ethanol or water / ethanol mixtures, can be obtained as well as press juice, are preferred.

It is possible to use both the extracts both in the original extractant and extracts / compressed juice in water or other organic solvents and / or mixtures thereof, in particular ethanol and ethanol / water mixtures. Preferably, extracted or pressed material is used as a solid to which the solvent (in particular as gently as possible) was removed. However, it is also possible to use those extracts / compressed juices to which the solvent has been partly removed, so that a thickened extract / compressed juice is used. Very particular preference is given to pressed juices from the fresh Echinacea purpurea herb (Echinacea purpurea Moench herba). In particular, the extracts and / or pressed juices in solid form.

Particularly according to the invention preferred hair cleansers are characterized in that they - based on their weight - 0.001 to 10 wt .-%, in particular 0.01 to 2% by weight of active substance (= plant extract).

additionally to all of the aforementioned ingredients may as a particularly preferred Component of all compositions according to the invention to serve a silicone. Silicones can also be used in the invention Means to perform various functions. So can on the one hand as a structuring agent, but also as a skin and hair care product serve - their use in the invention Compositions are thus also particularly preferred.

silicones be in the compositions of the invention in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 5% by weight and in particular from 0.5 to 2.5 wt .-%, each based on the entire composition, used.

• (i) Polyalkylsiloxanen, Polyarylsiloxanen, Polyalkylarylsiloxanen, die flüchtig oder nicht flüchtig, geradkettig, verzweigt oder cyclisch, vernetzt oder nicht vernetzt sind;
• (ii) Polysiloxanen, die in ihrer allgemeinen Struktur eine oder mehrere organofunktionelle Gruppen enthalten, die ausgewählt sind unter: a) substituierten oder unsubstituierten aminierten Gruppen; b) (per)fluorierten Gruppen; c) Thiolgruppen; d) Carboxylatgruppen; e) hydroxylierten Gruppen; f) alkoxylierten Gruppen; g) Acyloxyalkylgruppen; h) amphoteren Gruppen; i) Bisulfitgruppen; j) Hydroxyacylaminogruppen; k) Carboxygruppen; l) Sulfonsäuregruppen; und m) Sulfat- oder Thiosulfatgruppen;
• (iii) linearen Polysiloxan(A)-Polyoxyalkylen(B)-Blockcopoylmeren vom Typ (A-B)_n mit n > 3;
• (iv) gepfropften Siliconpolymeren mit nicht siliconhaltigem, organischen Grundgerüst, die aus einer organischen Hauptkette bestehen, welche aus organischen Monomeren gebildet wird, die kein Silicon enthalten, auf die in der Kette sowie gegebenenfalls an mindestens einem Kettenende mindestens ein Polysiloxanmakromer gepfropft wurde;
• (v) gepfropften Siliconpolymeren mit Polysiloxan-Grundgerüst, auf das nicht siliconhaltige, organische Monomere gepfropft wurden, die eine Polysiloxan-Hauptkette aufweisen, auf die in der Kette sowie gegebenenfalls an mindestens einem ihrer Enden mindestens ein organisches Makromer gepfropft wurde, das kein Silicon enthält;
• (vi) oder deren Gemischen.

Particular preference is given to agents according to the invention which comprise at least one silicone selected from:

• (i) polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
• (ii) polysiloxanes containing in their general structure one or more organofunctional groups selected from: a) substituted or unsubstituted aminated groups; b) (per) fluorinated groups; c) thiol groups; d) carboxylate groups; e) hydroxylated groups; f) alkoxylated groups; g) acyloxyalkyl groups; h) amphoteric groups; i) bisulfite groups; j) hydroxyacylamino groups; k) carboxy groups; l) sulfonic acid groups; and m) sulfate or thiosulfate groups;
• (iii) linear polysiloxane (A) polyoxyalkylene (B) block copolymers of the (AB) _{n type} with n>3;
• (iv) grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
• (v) grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ;
• (vi) or mixtures thereof.

Particularly preferred agents are characterized in that they contain at least one silicone of the formula (Si-I) (CH ₃ ) ₃ Si- [O-Si (CH ₃ ) ₂ ] _x -O-Si (CH ₃ ) ₃ (Si-I), in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.

The inventively preferred means comprise a silicone of the above formula I. These silicones are referred to according to the INCI nomenclature as DIMETHICONE. In the context of the present invention, as the silicone of the formula (Si-1), the compounds are preferably:
(CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₃ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₄ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₅ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₇ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₈ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₉ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₀ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₁ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₂ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₃ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₄ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₅ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₇ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₈ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₉ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂₀ -O-Si (CH ₃ ) ₃
where (CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O-Si (CH ₃ ) ₃ and / or (CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) _{3 are} particularly preferred.

Of course can also mixtures of o. g. Silicones in the invention Be included means.

According to the invention preferred Agents contain dimethicones, d. H. Silicones of the formula Si-I, in narrower quantities. Here are cosmetic according to the invention Medium preferred, which - based on their weight - 0.02 to 8.5% by weight, preferably 0.1 to 7.5% by weight, more preferably 0.25 to 5 wt .-%, more preferably 0.25 to 4 wt .-% and in particular 0.3 to 2.5 wt .-% of at least one silicone of the formula Si-I included.

The silicones of formula Si-I may have degrees of oligomerization or polymerization between 0 (corresponding to (CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃ ) and 500, with preferred degrees of oligomerization or polymerization ranging from 10 to 2500 , more preferably from 50 to 1500, and especially from 100 to 1000. Naturally, the molecular weight of the dimethicones varies with the degree of oligomerization or polymerization and is between 162 daltons (for the above-mentioned degree of oligomerization 0) and a few 100 kDa for high degrees of polymerization, for example about 60 kDa for a degree of polymerization of 810.

The viscosity of the dimethicones used according to the invention is almost independent of temperature and varies with the molar mass, with high molecular weight dimethicones having higher viscosities than low molecular weight ones. At normal measuring conditions (20 ° C., 1013.25 mbar), (CH ₃ ) ₃ Si-O-Si (CH ₃ ) _{3 has} a viscosity of 0.65 mm ² / s (centistokes, cSt), this viscosity also being hardly dependency on the measuring apparatus shows. For example, the viscosity at the above-mentioned normal measurement conditions can be measured with a Brookfield LVT viscometer, spindle 2, 30 rpm. Viscosity data in the context of the present application always refer to 20 ° C and 1013.25 mbar and on apparatuses in which under these conditions, a viscosity of (CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃ of 0.65 mm ² / s (centistokes, cSt) is measured.

Particularly according to the invention preferred cosmetic agents are characterized in that they contain as silicon of the formula Si-I a Dimethicone, which is a Viscosity of 10 to 1,000,000 cSt, preferably 100 to 600,000 cSt, more preferably from 1000 to 300,000 cSt, on preferably from 5000 to 200,000 cSt and in particular from 10,000 to 70,000 cSt (measured at 20 ° C) has.

Particularly preferred dimethicones which can be used according to the invention have degrees of polymerization of between 700 and 1400. Particularly preferred cosmetic agents according to the invention are characterized in that at least 25% by weight, preferably at least 50% by weight, particularly preferably at least 75% by weight, more preferably at least 95% by weight and in particular 100% by weight of silicones of the formula Si-I contained in the middle are / are selected from silicones of the formula Si-I (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] _x -O-Si (CH ₃ ) ₃ (Si-I) in the x for a number from the group 800, 801, 802, 803, 804, 805, 806, 807, 808, 809, 810, 811, 812, 813, 814, 815, 816, 817, 818, 819, 820, 821, 822, 823, 824, 825, 826, 827, 828, 829, 830, 831, 832, 833, 834, 835, 836, 837, 838, 839, 840, 841, 842, 843, 844, 845, 846, 847, 848, 849, 850, 851, 852, 853, 854, 855, 856, 857, 858, 859, 860, 861, 862, 863, 864, 865, 866, 867, 868, 869, 870, 871, 872, 873, 874, 875, 876, 877, 878, 879, 880, 881, 882, 883, 884, 885, 886, 887, 888, 889,890,891,892,893,894,895,896,897,898,899,900,901,902,903,904,905,906,907,908,909,910,911,912,913, 914, 915, 916, 917, 918, 919, 920, 921, 922, 923, 924, 925, 926, 927, 928, 929, 930, 931, 932, 933, 934, 935, 936, 937, 938, 939, 940, 941, 942, 943, 944, 945, 946, 947, 948, 949, 950, 951, 952, 953, 954, 955, 956, 957, 958, 959, 960, 961, 962, 963, 964, 965, 966, 967, 968, 969, 970, 971, 972, 973, 974, 975, 976, 977, 978, 979, 980, 981, 982, 983, 984, 985, 986, 987, 988, 989, 990, 991, 992, 993, 994, 995, 996, 997, 998, 999, 1000, 1001, 1002, 1003, 1004, 1005, 1006, 1007, 1008, 1009, 1010, 1011 , 1012, 1013, 1014, 1015, 1016, 1017, 1018, 1019, 1020, 1021, 1022, 1023, 1024, 1025, 1026, 1027, 1028, 1029, 1030, 1031, 1032, 1033, 1034, 1035, 1036 , 1037, 1038, 1039, 1040, 1041, 1042, 1043, 1044, 1045, 1046, 1047, 1048, 1049, 1050, 1051, 1052, 1053, 1054, 1055, 1056, 1057, 1058, 1059, 1060, 1061 , 1062, 1063, 1064, 1065, 1066, 1067, 1068, 1069, 1070, 1071, 1072, 1073, 1074, 1075, 1076, 1077, 1078, 1079, 1080, 1081, 1082, 1083, 1084, 1085, 1086 , 1087, 1088, 1089, 1090, 1091, 1092, 1093, 1094, 1095, 1096, 1097, 1098, 1099, 1100.

Accordingly, particularly preferred agents according to the invention contain silicones of the formula Si-I which are selected from the dimethicones (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₀₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₀₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₀₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₀₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₀₄ - O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 805} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH ₃ ) ₂ ] ₈₀₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₀₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₀₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₀₉ -O-Si (CH ₃ ) ₃ , ( CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₁ -O-Si ( CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₆ -O-Si (CH ₃ ) ₃ , ( CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₈ -O-Si ( CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₁₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₇ -O- Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₂₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₃₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O -Si (CH ₃ ) ₂ ] ₈₃₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₃₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₃₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₃₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₃₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] _{83 6} -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₃₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₃₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₃₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₃ -O- Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O -Si (CH ₃ ) ₂ ] ₈₄₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₄₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₅₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₅₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₅₂ O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 853} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH ₃ ) ₂ ] ₈₅₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₅₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₅₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₅₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₅₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₅₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₆₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₆₁ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 862} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH ₃ ) ₂ ] ₈₆₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₆₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₆₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₆₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₆₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₆₈ -O -Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₆₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₇₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₇₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [ O-Si (CH ₃ ) ₂ ] ₈₇₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₇₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₇₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₇₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₇₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₇₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₇₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si ( CH ₃ ) ₂ ] ₈₇₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₈₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH _{3) 2] 881} -0-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 882} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 883} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2]} -O-Si ₈₈₄ (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₈₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₈₆ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 887} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH ₃ ) ₂ ] ₈₈₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₈₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₁ -O-Si (CH ₃ ) ₃ ] (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₃ -O -Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [ O-Si (CH ₃ ) ₂ ] ₈₉₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₈₉₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₀₀ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 901} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 902} -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₀₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si ( CH ₃ ) ₂ ] ₉₀₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₀₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] ₉₀₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₀₇ -O-Si (CH ₃ ) ₃ , (CH _{3) 3} Si- [O-Si (CH _{3) 2] 908} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2]} -O-Si ₉₀₉ (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] ₉₁₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] ₉₁₁ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 912} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH ₃ ) ₂ ] ₉₁₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₁₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₁₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₁₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₁₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₁₈ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 919} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si ( CH ₃ ) ₂ ] ₉₂₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₂₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₃₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₃₁ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 932} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH ₃ ) ₂ ] ₉₃₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₃₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₃₅ -O-Si (CH ₃ ) ₃ , CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₃₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] ₉₃₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] ₉₃₈ -O- Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₃₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₄₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₄₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O -Si (CH ₃ ) ₂ ] ₉₄₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₄₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₄₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₄₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₄₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] _{94 7} -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₄₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₄₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₅₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si- [O-Si (CH _{3) 2] 951} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 952} -O-Si (CH _{3) 3} , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₅₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₅₄ -O- Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₅₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) _{2] 956} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 957} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O -Si (CH ₃ ) ₂ ] ₉₅₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₅₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si- [O-Si (CH _{3) 2] 960} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 961} -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₆₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₆₃ O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 964} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH ₃ ) ₂ ] ₉₆₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₆₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ S i- [O-Si (CH ₃ ) ₂ ] ₉₆₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₆₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₆₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₀ -O- Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O -Si (CH ₃ ) ₂ ] ₉₇₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₇₉ - O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₈₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH _{3) 2] 981} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 982} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH ₃ ) ₂ ] ₉₈₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₈₄ -O-Si (CH ₃ ) ₃ , ( CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₈₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₈₆ -O-Si ( CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₈₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₈₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₈₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si ( CH _{3) 2] 990} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 991} -O-Si (CH _{3) 3,} (CH _{3) 3} Si [O-Si (CH ₃ ) ₂ ] ₉₉₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₉₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₉₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₉₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₉₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₉₉₇ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] 998} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH ₃ ) ₂ ] ₉₉₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₀₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si- [O-Si (CH _{3) 2] in 1001} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1002} -O-Si (CH _{3) 3} , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₀₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₀₄ -O -Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₀₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-] Si (CH ₃ ) ₂ ] ₁₀₀₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₀₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₀₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₀₉ -O-Si (CH ₃ ) _3, (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1010} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2]} -O ₁₀₁₁ -Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1012} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH ₃ ) _{2] 1013} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1014} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [ O-Si (CH _{3) 2] in 1015} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1016} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1017} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1018} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1019} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1020} -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₂₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si ( CH _{3) 2] in 1022} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1023} -O-Si (CH _{3) 3,} (CH _{3) 3} Si - [O-Si (CH ₃ ) ₂ ] ₁₀₂₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] ₁₀₂₅ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1026} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH _{3) 2] in 1027} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1028} -O-Si (CH _{3) 3,} CH _{3) 3} Si [O-Si (CH ₃ ) ₂ ] ₁₀₂₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₃₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₃₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₃₂ -O- Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1033} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2} ] ₁₀₃₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₃₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O -Si (CH ₃ ) ₂ ] ₁₀₃₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₃₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₃₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₃₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₄₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₄₁ - O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1042} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1043} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2]} -O-Si ₁₀₄₄ ( CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₄₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₄₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₄₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₄₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₄₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₅₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₅₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₅₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₅₃ -O- Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₅₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) _{2] 1055} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1056} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O -Si (CH ₃ ) ₂ ] ₁₀₅₇ - O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] ₁₀₅₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₅₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₆₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₆₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₆₂ - O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₆₃ -O-Si (CH ₃ ) ₃ , (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1064} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2]} -O-Si ₁₀₆₅ (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₆₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₆₇ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1068} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH ₃ ) ₂ ] ₁₀₆₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₇₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₇₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₇₂ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₇₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₇₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₇₅ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1076} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH ₃ ) ₂ ] ₁₀₇₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₇₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₇₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₂ -O -Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [ O-Si (CH ₃ ) ₂ ] ₁₀₈₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₈₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₉₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O-Si (CH ₃ ) ₂ ] ₁₀₉₁ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₉₂ -O-Si (CH ₃ ) ₃ , (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1093} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2]} -O-Si ₁₀₉₄ (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₉₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₉₆ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O-Si (CH _{3) 2] in 1097} -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [O- Si (CH ₃ ) ₂ ] ₁₀₉₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₀₉₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] ₁₁₀₀ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] -O-Si (CH ₃ ) ₃ as well as mixtures of these substances.

• – k für Werte von 1 bis 20, vorzugsweise von 2 bis 10 und insbesondere für 2, 3, 4, 5, 6 steht;
• – m für Werte von 0 bis 100, vorzugsweise von 2 bis 50, besonders bevorzugt von 5 bis 35 und insbesondere für 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 steht;
• – n für Werte von 0 bis 100, vorzugsweise von 0 bis 50, besonders bevorzugt von 0 bis 35 und insbesondere für 0, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 steht;
• – x bzw. y jeweils unabhängig voneinander für eine Zahl von 0 bis 5000, vorzugsweise von 10 bis 2500, weiter bevorzugt von 50 bis 1500 und insbesondere 100 bis 1000 stehen,

mit der Maßgabe, dass (m + n) nicht Null ist.In addition, the compositions according to the invention may contain - or instead of the dimethicones - at least one silicone of the formula Si-II (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] _x - [O- (H ₃ C) Si ((CH ₂ ) _k (CH ₂ CH ₂ O) _m (CH ₂ CH ₂ CH ₂ O ) _n )] _x -O-Si (CH ₃ ) ₃ (Si-II), included in the

• K is from 1 to 20, preferably from 2 to 10 and especially from 2, 3, 4, 5, 6;
• M is from 0 to 100, preferably from 2 to 50, more preferably from 5 to 35 and especially for 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ;
• N for values from 0 to 100, preferably from 0 to 50, particularly preferably from 0 to 35 and in particular for 0, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 stands;
• Each of x and y independently represents a number from 0 to 5000, preferably from 10 to 2500, more preferably from 50 to 1500 and in particular from 100 to 1000,

with the proviso that (m + n) is not zero.

at these silicones is a methyl group of some dimethylsiloxane replication units replaced by an ethoxylated and / or propoxylated alkylene group, whereby these silicones are water-soluble. According to the INCI nomenclature Silicones of the formula Si-II are called dimethicone copolyols.

According to the invention preferred Agents contain dimethicone copolyols, d. H. Silicones of the formula Si-II, in smaller quantities. Here are inventive preferred cosmetic agents, which - based on their weight - 0.02 to 8.5% by weight, preferably 0.1 to 7.5% by weight, more preferably 0.25 to 5 wt .-%, more preferably 0.25 to 4 wt .-% and in particular 0.3 to 2.5 wt .-% of at least one silicone of the formula Si-II.

Also the silicones of formula Si-II can be oligomerization or degrees of polymerization between 0 and 5000, with preferred Oligomerization or polymerization degrees in the range of 10 to 2500, more preferably from 50 to 1500 and especially from 100 to 1000 lie. Naturally, the molecular weight varies the dimethicone copolyols also with the oligomerization or Polymerization.

Dimethicone copolyols present in the compositions according to the invention have the polymerization degrees x (for the unsubstituted dimethylsiloxane unit) or y (for the substituted dimethylsiloxane unit). Although theoretically "total" degrees of polymerization (sum x + y) of up to 10,000 are possible according to the definition of x and y, agents according to the invention are preferred in which the sum x + y ranges from 10 to 2500, more preferably from 50 to 1500 and in particular from 100 to 1000 lies. The representation in formula Si-II is schematic. It does not mean that the substituted and unsubstituted dimethylsiloxane units must be in blocks; rather, the - [O-Si (CH ₃ ) ₂ ] _x units and the - [O- (H ₃ C) Si ((CH ₂ ) _k (CH ₂ CH ₂ O) _m (CH ₂ CH ₂ CH ₂ O) _n )] _y units are also "randomized", ie distributed statistically over the molecule.

The viscosity of the dimethicone copolyols used according to the invention is likewise almost independent of temperature and varies with the molar mass, with high molecular weight dimethicone copolyols having higher viscosities than low molecular weight. Here, cosmetic agents according to the invention are preferred which are known as Si of the formula Si-II contain a dimethicone copolyol having a viscosity of from 1 to 10,000 cSt, preferably from 10 to 5000 cSt, more preferably from 50 to 2500 cSt, more preferably from 100 to 1000 cSt and in particular from 300 to 500 cSt ( measured at 20 ° C).

According to the invention, the degree of ethoxylation m is 0 to 100, preferably 2 to 50, particularly preferably 5 to 35 and in particular 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20. The propoxylation degree n is from 0 to 100, preferably from 0 to 50, more preferably from 0 to 35 and especially for 0, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 Here, too, the formulaic formula in the formula Si-II does not mean that the ethylene oxide units must necessarily be bound to the alkylene group which is bonded to the Si atom. Rather, EO and PO units can also be reversed so that one - [O- (H ₃ C) Si ((CH ₂ ) _k (CH ₂ CH ₂ CH ₂ O) _m (CH ₂ CH ₂ O) _n ) ] _y unit is also possible. Again, the sequence EO _m PO "does not necessarily mean that the EO or PO units must be in blocks; Rather, the EO and PO units can also be "randomized", ie distributed statistically over the molecule.

The alkylene group in formula Si-II is preferably a linear alkylene group in which k is from 1 to 20, preferably from 2 to 10 and especially from 2, 3, 4, 5, 6. Preference is therefore given to the groupings -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ -CH ₂ -CH ₂ -, -CH ₂ -CH ₂ -CH ₂ -CH ₂ -, -CH ₂ -CH ₂ - CH ₂ -CH ₂ -CH ₂ -, -CH ₂ -CH ₂ -CH ₂ -CH ₂ -CH ₂ -CH ₂ -CH ₂ -CH ₂ -CH ₂ -CH ₂ -.

Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may, for. B. by the formula M (R _a Q _b SiO _{(4-ab) / 2) x} (R _c SiO _{(4-c) / 2) y} M wherein R in the above formula is a hydrocarbon or a hydrocarbon group of 1 to about 6 carbon atoms, Q is a polar group of the general formula -R ¹ HZ wherein R ^{1 is} a divalent linking group attached to hydrogen and the group Z is an organic, amino-functional radical containing at least one amino-functional group, carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms; "A" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" is less than or equal to 3, and "c" is a number in the range from about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000 , preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ ) ₃ CC (O) OCH ₂ CH ₂ -, C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _z NH ₂ , wherein z is 1 or more. Another possible formula for Z is -NH (CH ₂ ) _z (CH ₂ ) _zz NH, wherein both z and zz are independently 1 or more, this structure comprising diamino ring structures, such as piperazinyl. Z is most preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is -N (CH ₂ ) _z (CH ₂ ) _zz NX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.

Q is most preferably a polar, amine functional group of the formula -CH ₂ CH ₂ CH ₂ NHCH ₂ CH ₂ NH ₂ . In the formulas, "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 2 to about 3, "a" + "b" is less than or equal to 3, and "c "Is a number in the range of about 1 to about 3. The molar ratio of the R _a Q _b SiO _{(4-ab) / 2} units to the R _c SiO _{(4-c) / 2} units is in the range of about 1: 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1:15 to about 1:20. When one or more silicones of the above formula are used, the various variable substituents in the above formula may be present on the various silicone components present in the silicone blend are, be different.

Preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-III) R _'a G _3-a -Si (OSiG _{2) n} - (OSiG _b R' _{2-b) m} -O-SiG _3-a -R _'a (Si-III), contain, in which means:
G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -O-CH ₂ CH ₃ , -CH ₂ CH ₃ , -O-CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -O-CH (CH ₃ ) ₂ , -CH (CH ₃ ) ₂ , -O-CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₂ CH ₃ , -O-CH ₂ CH ( CH ₃ ) ₂ , -CH ₂ CH (CH ₃ ) ₂ , -O-CH (CH ₃ ) CH ₂ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -OC (CH ₃ ) ₃ , -C ( CH ₃ ) ₃ ;
a is a number between 0 and 3, in particular 0;
b stands for a number between 0 and 1, in particular 1,
m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,
R 'is a monovalent radical selected from
-QN (R ") - CH ₂ -CH ₂ -N (R") ₂
-QN (R '') ₂
-QN ⁺ (R '') ₃ A ^-
-QN ⁺ H (R '') ₂ A ^-
-QN ⁺ H ₂ (R '') A ^-
-QN (R ") - CH ₂ -CH ₂ -N ⁺ R''H ₂ A ^- ,
wherein each Q is a chemical bond, -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ CH ₂ CH ₂ -, -C (CH ₃ ) ₂ -, -CH ₂ CH ₂ CH ₂ CH ₂ -, -CH ₂ C (CH ₃ ) ₂ -, -CH (CH ₃ ) CH ₂ CH ₂ -,
R '' is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C ( CH ₃ ) ₃ , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.

enthalten, worin m und n Zahlen sind, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIIa)

in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.

These Silicones are classified as trimethylsilylamodimethicones according to the INCI declaration designated.

enthalten, worin R für -OH, -O-CH₃ oder eine -CH₃-Gruppe steht und m, n1 und n2 Zahlen sind, deren Summe (m + n1 + n2) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei die Summe (n1 + n2) vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Also preferred are agents according to the invention which contain at least one amino-functional silicone of the formula (Si-IIIb)

in which R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These Silicones are called amodimethicones according to the INCI declaration.

Regardless of which amino-functional silicones are employed, agents according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g, are preferred , The amine number is here for the milliequivalents of amine per gram of amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.

According to the invention preferred Agents are characterized by having 0.01, based on their weight to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and in particular 0.5 to 5% by weight of amino-functional (s) Silicone (s) included.

enthalten, in der x für eine Zahl von 3 bis 200, vorzugsweise von 3 bis 10, weiter bevorzugt von 3 bis 7 und insbesondere 3, 4, 5 oder 6, steht.The INCI CYCLOMETHICONE designated cyclic dimethicones are inventively used with preference. Here, agents according to the invention are preferred which contain at least one silicone of the formula (Si-IV)

in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.

The silicones described above have a backbone, which is composed of -Si-O-Si units. Of course These Si-O-Si units can also be replaced by carbon chains be interrupted. Corresponding molecules are by chain extension reactions accessible and preferably come in the form of silicone-in-water emulsions for use.

Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula (Si-V) R _{3 is} -Si- [O-SiR ₂ ] _x - (CH ₂ ) _n - [O-SiR ₂ ] _y -O-SiR ₃ (Si-V), in which R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , - C (CH ₃ ) ₃ , x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, stand and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6.

at the antidandruff agents according to the invention It is preferably a shampoo, a shower, a shower gel, a Conditioner, a hair conditioner, a hair tonic, a hair gel, a Hair spray, a lather, a tightening agent, a aftershave or a Deodorant.

In a particularly preferred embodiment is a shampoo.

• – Anlagerungsprodukte von 4 bis 30 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,
• – C₁₂-C₂₂-Fettsäuremono- und diester von Anlagerungsprodukten von 1 bis 60 Mol Ethylenoxid an Polyole mit 3 bis 6 Kohlenstoffatomen, insbesondere an Glycerin,
• – Ethylenoxid- und Polyglycerin-Anlagerungsprodukte an Methylglucosid-Fettsäureester, Fettsäurealkanolamide und Fettsäureglucamide,
• – C₈-C₂₂-Alkylmono- und oligoglycoside und deren ethoxylierte Analoga, wobei Oligomerisierungsgrade von 1,1 bis 5, insbesondere 1,2 bis 2,0, und Glucose als Zuckerkomponente bevorzugt sind,
• – Gemische aus Alkyl-(oligo)-glucosiden und Fettalkoholen zu Beispiel das im Handel erhältliche Produkt Montanov^® 68,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Partialester von Polyolen mit 3 bis 6 Kohlenstoffatomen mit gesättigten Fettsäuren mit 8 bis 22 C-Atomen,
• – Sterine. Als Sterine wird eine Gruppe von Steroiden verstanden, die am C-Atom 3 des Steroid-Gerüsts eine Hydroxylgruppe tragen und sowohl aus tierischem Gewebe (Zoosterine) wie auch aus pflanzlichen Fetten (Phytosterine) isoliert werden. Beispiele für Zoosterine sind das Cholersterin und das Lanosterin. Beispiele geeigneter Phytosterine sind Ergosterin, Stigmasterin und Sitosterin. Auch aus Pilzen und Hefen werden Sterine, die sogenannten Mykosterine, isoliert.
• – Phospholipide. Hierunter werden vor allem die Glucose-Phospholipide, die z. B. als Lecithine bzw. Phosphatidylcholine aus z. B. Eidotter oder Pflanzensamen (z. B. Sojabohnen) gewonnen werden, verstanden.
• – Fettsäureestervon Zuckern und Zuckeralkoholen, wie Sorbit,
• – Polyglycerine und Polyglycerinderivate wie beispielsweise Polyglycerinpoly-12-hydroxystearat (Handelsprodukt Dehymuls^® PGPH),
• – Lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen und deren Na-, K-, Ammonium-, Ca-, Mg- und Zn-Salze.

In a further preferred embodiment, the effect of the active ingredient combination according to the invention can be increased by emulsifiers. Such emulsifiers are, for example

• Addition products of from 4 to 30 mol of ethylene oxide and / or from 0 to 5 mol of propylene oxide onto linear fatty alcohols having from 8 to 22 carbon atoms, to fatty acids containing from 12 to 22 carbon atoms and to alkylphenols having from 8 to 15 carbon atoms in the alkyl group,
• C ₁₂ -C ₂₂ fatty acid mono- and diesters of addition products of from 1 to 60 moles of ethylene oxide onto polyols having from 3 to 6 carbon atoms, in particular to glycerol,
• Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters, fatty acid alkanolamides and fatty acid glucamides,
• C ₈ -C ₂₂ -alkyl mono- and oligoglycosides and their ethoxylated analogues, preference being given to degrees of oligomerization of from 1.1 to 5, in particular from 1.2 to 2.0, and glucose as the sugar component,
• Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ^® Montanov 68, -
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• Partial esters of polyols having 3 to 6 carbon atoms with saturated fatty acids having 8 to 22 C atoms,
• - sterols. Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
• - Phospholipids. Of these, especially the glucose phospholipids z. B. as lecithin or Phos phatidyl choline from e.g. Egg yolks or plant seeds (eg soybeans) are understood.
• Fatty acid esters of sugars and sugar alcohols, such as sorbitol,
• - polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ^® PGPH),
• - Linear and branched fatty acids with 8 to 30 carbon atoms and their Na, K, ammonium, Ca, Mg and Zn salts.

The agents according to the invention contain the emulsifiers preferably in amounts of 0.1-25 wt .-%, in particular 0.5-15 Wt .-%, based on the total agent.

The compositions according to the invention may preferably comprise at least one nonionic emulsifier having an HLB value of 8 to 18, according to the methods described in US Pat Rompp Lexicon Chemistry (ed. J. Falbe, M. Regitz), 10th edition, Georg Thieme Verlag Stuttgart, New York, (1997), page 1764 , listed definitions. Nonionic emulsifiers with an HLB value of 10-15 may be particularly preferred according to the invention.

• – Verdickungsmittel wie Agar-Agar, Guar-Gum, Alginate, Xanthan-Gum, Gummi arabicum, Karaya-Gummi, Johannisbrotkernmehl, Leinsamengummen, Dextrane, Cellulose-Derivate, z. B. Methylcellulose, Hydroxyalkylcellulose und Carboxymethylcellulose, Stärke-Fraktionen und Derivate wie Amylose, Amylopektin und Dextrine, Tone wie z. B. Bentonit oder vollsynthetische Hydrokolloide wie z. B. Polyvinylalkohol,
• – haarkonditionierende Verbindungen wie Phospholipide, beispielsweise Sojalecithin, Ei-Lecitin und Kephaline, sowie Silikonöle,
• – Parfümöle, Dimethylisosorbid und Cyclodextrine,
• – Lösungsmittel und -vermittler wie Ethanol, Isopropanol, Ethylenglykol, Propylenglykol, Glycerin und Diethylenglykol,
• – faserstrukturverbessernde Wirkstoffe, insbesondere Mono-, Di- und Oligosaccharide, wie beispielsweise Glucose, Galactose, Fructose, Fruchtzucker und Lactose,
• – Entschäumer wie Silikone,
• – Farbstoffe zum Anfärben des Mittels,
• – Weitere Antischuppenwirkstoffe wie Piroctone Olamine, Zink Omadine und Climbazol,
• – Wirkstoffe wie Allantoin und Bisabolol, Cholesterin,
• – Konsistenzgeber wie Zuckerester, Polyolester oder Polyolalkylether,
• – Fette und Wachse wie Walrat, Bienenwachs, Montanwachs und Paraffine,
• – Fettsäurealkanolamide,
• – Komplexbildner wie EDTA, NTA, β-Alanindiessigsäure und Phosphonsäuren,
• – Quell- und Penetrationsstoffe wie primäre, sekundäre und tertiäre Phosphate,
• – Trübungsmittel wie Latex, Styrol/PVP- und Styrol/Acrylamid-Copolymere,
• – Perlglanzmittel wie Ethylenglykolmono- und -distearat sowie PEG-3-distearat,
• – Pigmente,
• – Treibmittel wie Propan-Butan-Gemische, N₂O, Dimethylether, CO₂ und Luft,
• – Antioxidantien.

Other active ingredients, auxiliaries and additives are, for example

• Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. For example, methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. As bentonite or fully synthetic hydrocolloids such. For example, polyvinyl alcohol,
• Hair-conditioning compounds such as phospholipids, for example soya lecithin, egg lecithin and cephalins, and silicone oils,
• Perfume oils, dimethylisosorbide and cyclodextrins,
• Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol,
• Fiber-structure-improving active substances, in particular mono-, di- and oligosaccharides, such as, for example, glucose, galactose, fructose, fructose and lactose,
• Defoamers like silicones,
• Dyes for staining the agent,
• - Other anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
• - active substances such as allantoin and bisabolol, cholesterol,
• Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,
• - fats and waxes such as spermaceti, beeswax, montan wax and paraffins,
• Fatty acid alkanolamides,
• Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,
• - swelling and penetrating substances such as primary, secondary and tertiary phosphates,
• Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers,
• Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
• - pigments,
• Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air,
• - antioxidants.

The agents according to the invention are subject to their packaging form no restrictions and Can be used as an emulsion, cream, solution, gel or mousse be formulated.

One second subject of the invention is the cosmetic use of the anti-dandruff agent according to the invention Prophylaxis, reduction, elimination and / or palliation of dandruff on hairy body regions.

One third subject of the invention is the cosmetic use of the anti-dandruff agent according to the invention Reduction of relapse of dandruff on hairy Body regions after discontinuation of the remedy.

• A) einem anionischen Sulfat- und/oder Sulfonattensid,
• B) einem Zink-Pyrithion einer Partikelgröße < 2 μm und
• C) einem kationischen Polygalactomannan oder einem Derivats des kationischen Polygalactomannans mit einer kationischen Ladungsdichte von 0,1 bis 1,5 meq/g und einem Molekulargewicht von 500,000 bis 3,000,000.

zur Herstellung eines Präparats zur Behandlung von Hautschuppen.A fourth object of the invention is the cosmetic use of a combination of

• A) an anionic sulphate and / or sulphonate surfactant,
• B) a zinc Pyrithion a particle size <2 microns and
• C) a cationic polygalactomannan or a derivative of the cationic polygalactomannan having a cationic charge density of 0.1 to 1.5 meq / g and a molecular weight of 500,000 to 3,000,000.

for the preparation of a preparation for the treatment of dander.

One Fifth object of the invention is a cosmetic method for the prophylaxis, reduction, elimination and / or alleviation of Dandruff on hairy body regions in which an inventive Antidandruff applied to the hair or hairy skin is rinsed out and, if appropriate, after a contact time again becomes.

The The following examples are intended to explain the invention in more detail, without restricting it to it.

The listed quantities in the examples relate, Unless indicated otherwise, by weight.

Examples:

• ¹ INCI-Bezeichnung: Hydtrogenated Castor Oil; Cognis
• ² INCI-Bezeichnung: PEG-7 Glyceryl Cocoate; Cognis
• ³ INCI-Bezeichnung: Guar Hydroxypropyltrimonium Chloride; Hercules
• ⁴ INCI-Bezeichnung: Hydrolysed Keratin, Aqua; Croda
• ⁵ INCI-Bezeichnung: PEG-55 Propylene Glycol Oleate, Propylene Glycol; Goldschmidt
• ⁶ INCI-Bezeichnung: Laureth-2; Cognis
• ⁷ INCI-Bezeichnung: Coco Glucoside, Aqua; Cognis
• ⁸ INCI-Bezeichnung: PEG-120 Methyl Glucose Dioleate; Noveon

Shampoo 1 Sodium lauryl ether sulfate (2 EO) (AS) 11.00% Cocamidopropylbetaine (AS) 2.50% D-panthenol 0.15% nicotinamide 0.15% Cutina ^® HR ¹ 0.25% Cetiol ^® HE ² 1.00% N- ^Hance® 3196 ³ 0.15% Zinc pyrithione according to the invention 1.00% sodium benzoate 0.50% Perfume 0.15% sodium chloride 1.50% NaOH, citric acid, dye qs water ad 100% Shampoo 2 Sodium lauryl ether sulfate (2 EO) (AS) 5.60% Cocamidopropylbetaine (AS) 4.20% D-panthenol 0.20% ProSina ^{® 4} 0.15% Cutina ^® HR ¹ 0.20% Cetiol ^® HE ² 0.50% N-Hance 3196 ³ 0.25% Zinc pyrithione according to the invention 1.00% sodium benzoate 0.50% Perfume 0.15% Antil ^® 141 L ⁵ 0.07% Arlypon F ^{® 6} 0.20% Plantacare ^® 818UP ⁷ 2.00% Glucamate DOE 120 ^{® 8} 0.02% NaOH, citric acid, dye qs water ad 100%

• ¹ INCI name: Hydrogenated Castor Oil; Cognis
• ² INCI name: PEG-7 Glyceryl Cocoate; Cognis
• ³ INCI name: guar hydroxypropyltrimonium chlorides; Hercules
• ⁴ INCI name: Hydrolysed Keratin, Aqua; Croda
• ⁵ INCI name: PEG-55 Propylene Glycol Oleate, Propylene Glycol; Goldschmidt
• ⁶ INCI name: Laureth-2; Cognis
• ⁷ INCI name: Coco Glucoside, Aqua; Cognis
• ⁸ INCI name: PEG-120 methyl glucose dioleate; Noveon

QUOTES INCLUDE IN THE DESCRIPTION

This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.

Cited patent literature

• DE 19738866A [0029]
• DE 19756454 A [0095]
• - DE 4440625 A1 [0113]
• - DE 19503465 A1 [0113]
• - DE 3929973 A [0133]

Cited non-patent literature

• "International Cosmetic Ingredient Dictionary and Handbook," (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17th Street, NW, Suite 300, Washington, DC 20036-4702) [0118]
• - Rompp Lexicon Chemistry (ed. J. Falbe, M. Regitz), 10th edition, Georg Thieme Verlag Stuttgart, New York, (1997), page 1764 [0196]

Claims (14)

Antidandruff agent containing - related on his total weight - A) 0.5-20% by weight at least one anionic sulphate and / or sulphonate surfactant, B) 0.05 to 5 wt .-% zinc pyrithione a particle size <2 microns and C) 0.05 to 5 wt .-% of a cationic Polygalactomannans or a Derivative of the cationic polygalactomannan with a cationic Charge density of 0.1 to 1.5 meq / g and a molecular weight of 500,000 up to 3,000,000. Anti-dandruff agent according to claim 1, characterized in that that it has a pH <6, preferably <5.8 and in particular <5.5 having. Anti-dandruff agent according to one of the claims 1 or 2, characterized in that the anionic sulfate and / or Sulfonate surfactant A) a linear or branched alkyl chain of a Chain length from 6 to 20, preferably from 8 to 18 and in particular of 10 to 16 carbon atoms, and a degree of ethoxylation of 0 to 10, preferably from 1 to 8 and especially from 2 to 4. Anti-dandruff agent according to one of the claims 1 to 3, characterized in that at least 85%, preferably at least 90% and in particular at least 95% of the zinc pyrithione particles an average particle size <1.8 μm, preferably <1.5 μm, more preferably <1.3 μm and in particular <1.0 μm exhibit. Anti-dandruff agent according to one of the claims 1 to 4, characterized in that the cationic galactomannan or its derivative (C)) has a cationic charge density of 0.2 to 1.3 meq / g, preferably from 0.3 to 1.1 meq / g, and especially from 0.4 to 0.9 meq / g and a molecular weight of from 700,000 to 2,000,000, preferably from 900,000 to 1,750,000, more preferably from 1,000,000 up to 1,500,000 and especially from 1,150,000 to 1,400,000. Anti-dandruff agent according to one of the claims 1 to 5, characterized in that it further comprises at least one another surfactant selected from the group of amphoteric / zwitterionic and / or nonionic surfactants, wherein the Ratio of the anionic surfactant A) to the buzzer of the further surfactants in the range from 6: 1 to 1: 2, preferably from 5: 1 to 1: 1.5 and in particular in the range of 4.5: 1 to 1: 1.25. Anti-dandruff agent according to one of the claims 1 to 6, characterized in that it further comprises a care complex contains, the panthenol and at least one other Component that is selected from the group of other vitamins, vitamin precursors or vitamin derivatives and the Protein. Anti-dandruff agent according to one of the claims 1 to 7, characterized in that it further at least one "benefit agent ", which may be selected Antidandruff agents other than B), preservatives, UV filters, vegetable, animal, mineral and synthetic oils, Thickeners, polymers, humectants, hair structurants, Hair care preparations, hair restorers and hair loss preparations. Anti-dandruff agent according to claim 8, characterized in that that the composition is at least one component of the group contains, which is selected from vegetable oils, Silicones, fatty acids, fatty alcohols, amino acids and / or their derivatives, plant extracts, cationic polymers, which differ from C), cationic surfactants and hair structurants. Anti-dandruff agent according to one of the claims 1 to 9, characterized in that it is used as a shampoo, shower bath, Shower gel, conditioner, hair conditioner, hair lotions, hair gel, hair spray, Foam, stabilizer, aftershave or deodorant is present. Cosmetic use of an agent according to a of claims 1 to 10 for the prophylaxis, reduction, elimination and / or relieving dandruff on hairy body regions. Cosmetic use of an agent after one of claims 1 to 10 for reducing the relapse dandruff on hairy body regions after weaning of the agent. Cosmetic use of a combination of A) an anionic sulphate and / or sulphonate surfactant, D) a zinc pyrithione with a particle size <2 μm and E) a cationic polygalactomannan or a derivative of the cationic polygalactomannan with a cationic charge density of 0.1 to 1.5 meq / g and a molecular weight of 500,000 to 3,000,000. for the preparation of a preparation for the treatment of dander. Cosmetic method for prophylaxis, reduction, Removal and / or alleviation of dandruff on hairy body regions, wherein a cosmetic agent according to any one of claims 1 to 10 is applied to the hair or the hairy skin and optionally rinsed again after an exposure time becomes.